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ABSTRACT 
CHRISTINE MARIE TUCKER: Preterm Birth Prediction and Receipt of Postpartum 
Contraception among Participants of North Carolina’s Pregnancy Medical Home 
Program 
(Under the direction of Carolyn T. Halpern) 
 
 The purpose of this dissertation is to determine which combination of risk 
factors from Community Care of North Carolina’s Pregnancy Medical Home risk 
screening form is most predictive of preterm birth and to compare receipt of 
postpartum contraception for women who experienced a recent preterm birth with 
women who had a term birth. This retrospective cohort includes pregnant Medicaid 
beneficiaries screened by the program who delivered a live birth in North Carolina 
between September 2011 and September 2012. Data come from Community Care 
of North Carolina’s Case Management Information System, Medicaid claims, and 
birth certificates. The first paper of the dissertation designed and internally validated 
a predictive model of preterm birth using variables from the Pregnancy Medical 
Home risk screen. Logistic regression models and bootstrapping techniques 
indicated that the optimal combination of risk factors for PTB prediction include non-
Hispanic black race, smoking during pregnancy, underweight, multi-fetal gestation, 
chronic disease (diabetes, hypertension, asthma, renal disease, and other chronic 
conditions), cervical insufficiency, nulliparity, and previous adverse reproductive 
outcomes (history of preterm birth, low birth weight baby, fetal death, and second 
trimester loss). Salient risk factors were identified for subgroups by parity and 
iv 
race/ethnicity including obesity, food insecurity, unsafe or unstable housing, and a 
short interpregnancy interval. Evaluation of the Pregnancy Medical Home risk screen 
provides insight to increase its sensitivity and specificity to improve identification of 
women early in pregnancy at highest risk for preterm birth. The second paper 
compared the prevalence of contraceptive receipt and effectiveness in Medicaid 
claims among women with and without a recent preterm birth using logistic and 
multinomial logistic regression. Contraceptive receipt was 50% (25% for the most 
effective methods) for women who delivered preterm at 90 days postpartum 
compared to 52% (28% for the most effective methods) among women who 
delivered full term. Women with a recent preterm birth with more than two children 
had lower odds of receiving contraception compared to equal parity women who 
delivered at term (OR = 0.84, 95% CI: 0.74, 0.96). Care management should focus 
on the provision of effective methods of contraception to women with a recent 
preterm birth. 
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CHAPTER 1. INTRODUCTION 
PRETERM BIRTH AND HEALTH DISPARITIES 
Preterm birth (deliveries <37 completed weeks of gestation) is a major cause 
of infant mortality and morbidity.1,2 In 2009, 35% of infant deaths were ‘‘preterm-
related.’’2 Preterm birth (PTB) is associated with an array of short- and long-term 
health consequences. As detailed in the Institute of Medicine’s (IOM) report on PTB, 
preterm infants are at higher risk for neonatal intensive care admission, prolonged 
hospital stay due to morbidity in the first few weeks of life, re-hospitalization in the 
first years of life, and other longer-term outcomes such as respiratory, 
gastrointestinal, and neurodevelopmental complications.3 These health 
complications have a large societal cost as well as an emotional cost to parents and 
families. The IOM estimated the total annual economic burden of PTB in the United 
States in 2005 to be at least $426.2 billion.3 This translates into $51,600 spent per 
infant born preterm.3  
In the most recently available natality data from 2012, the prevalence of PTB 
was 11.55% nationally and highest for non-Hispanic black women (16.53%), 
followed by Hispanic women (11.58%), and non-Hispanic white women (10.29%).4 
The Healthy People 2020 goal is to reduce the preterm birth rate to 11.40%.5  
Racial-ethnic disparities in PTB over the past decade have not declined and 
the reasons for these disparities remain poorly understood.6-8 Goldenberg et al. 
(1996) found that maternal height, weight, blood pressure, diabetes, and smoking 
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were associated with preterm birth, however these factors did not explain the 
increased risk of PTB among black women compared to white women in Alabama.9 
In contrast, among a sample of low-income urban black women in Baltimore, MD, 
chronic disease pre-pregnancy was significantly associated with PTB.10 This finding 
is consistent with the “weathering hypothesis” that poorer overall health among black 
women in the United States contributes to their greater burden of preterm birth11 and 
supports the life course framework in the study of disparities in birth outcomes.12  
In addition to the prevalence of co-morbidities, other potential explanations for 
these disparities include differential access to care and quality of care, psychosocial 
stress, poverty, social context or environmental exposures, racism, preconception 
health differentials, infection/inflammation, and genetic factors.13–16 Unfortunately 
previous attempts to reduce disparities have not been successful.13 Improvement of 
birth outcomes in the United States hinges on our ability to better understand and 
reduce this racial gap.13,17 
In North Carolina, the setting of this dissertation, the prevalence of PTB is higher 
than the national average. In 2012, the National Center for Health Statistics (NCHS) 
calculated that 12% of births in NC were preterm.4 Racial/ethnic disparities in 
preterm birth have persisted for generations with non-Hispanic black women having 
the highest rates (16%).4,18 The concentration of PTB in communities of lower 
socioeconomic status places a burden on publicly financed health care.19 Over half 
of deliveries resulting in live births and 47% of prenatal care provided in NC in 2012 
were covered by Medicaid.18 According to the NC State Center for Health Statistics 
(SCHS), the PTB rate was 13% among resident live births to women on Medicaid in 
3 
2012, which appears lower than estimate for NC as a whole calculated by the NCHS 
using last menstrual period.20 
Risk Screening for Preterm Birth Prevention 
Since the 1970s, a multitude of researchers have attempted to develop risk 
screening tools to identify women early in pregnancy who will eventually deliver 
preterm.21,22 Despite enhanced understanding of multiple factors that increase the 
risk of PTB, no predictive model to date has been accurate enough to justify its use 
in the clinical setting.3,21–23 Previous risk scoring systems have only been able to 
identify a small proportion of women who have a PTB as high risk (low sensitivity), 
while a large proportion who have a PTB have been labeled as low risk (high false 
negative rate).21  
Risk screens typically consist of a questionnaire filled out by the patient or an 
oral history taken by the provider around the time of the first prenatal visit; 
sometimes a re-screen is conducted later in pregnancy to update the information.21 
Screening tools elicit information on sociodemographic factors, obstetric history, and 
characteristics of the current pregnancy in asymptomatic women.21 Risk factors are 
often added together to form a composite risk score. The weighting of each risk 
factor and the threshold at which women are considered to be high risk is often 
determined based on clinical knowledge or statistical analysis.21 From logistic 
regression models, predicted probabilities for each participant can be calculated and 
plotted using receiver operating characteristic (ROC) curve analyses to identify a 
threshold at which women should be considered high risk.21  
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To determine the usefulness of risk scoring systems in clinical practice, the 
sensitivity, specificity, and positive and negative predictive values of the instruments 
in relation to preterm birth can be calculated. More recently, methods to internally 
validate predictive models have been used such as split sample validation, cross-
validation, and bootstrapping.  
One example of an evaluation of a previous risk scoring system comes from 
the preterm birth prediction assessment system study conducted by Mercer et al. in 
the early 1990s.24 In this study, nearly 3,000 women with singleton pregnancies 
were recruited at 10 centers of the Maternal-Fetal Medicine Units Network prior to 24 
weeks gestation and assessed for information on demographic factors, home and 
work environment, drug and alcohol use, and medical history. The outcome of 
interest was spontaneous PTB prior to 37 weeks of gestation.  
Predictive models were developed separately among nulliparous and 
multiparous women using 85% of the sample and then validated in the remaining 
15% of the sample. For nulliparous women, black race, a poor social environment, 
paid employment, lung disease, a higher Bishop score (a score given to the cervix 
assessed by vaginal exam), low body mass index (BMI), and contractions were 
predictive of spontaneous preterm birth.24 Among multiparous women, a prior 
spontaneous preterm delivery, vaginal bleeding, low BMI, and increasing Bishop 
score was predictive of spontaneous PTB.  
These models were then validated in the remaining 15% of the sample to 
determine their predictive value. Predicted probabilities for each woman were 
calculated and a threshold of 20% was chosen to delineate women at high or low 
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risk. For nulliparous women, the sensitivity, specificity, positive predictive value, and 
negative predictive value of the model were 18.2, 95.4, 33.3, and 90.2, 
respectively.24 Though this assessment system was able to accurately predict 
women who did not go on to have a spontaneous PTB (high specificity), its ability to 
detect women who would have a spontaneous preterm delivery was poor (low 
sensitivity). The likelihood ratio for a positive test (women with a 20% probability or 
higher) was 3.9 (95% confidence interval (CI) 1.3–12.0) and the likelihood ratio for a 
negative test (women with less than a 20% probability) was 0.9 (95% CI 0.7–1.0).  
Model performance was slightly more selective for the multiparous sample, 
however other measures of test performance were lower. The sensitivity, specificity, 
positive predictive value, and negative predictive value of the model among 
multiparas were 24.2, 92.1, 30.8, and 89.4, respectively.24 The likelihood ratio for a 
positive test was 2.9 (95% CI 1.4–6.1) and for a negative test was 0.8 (95% CI 0.7–
1.0). The authors concluded that despite 84.6% of predictions being correct, the 
system does not identify most women who subsequently have a spontaneous 
preterm delivery.24 
In a systematic literature review of 19 articles through 2002 assessing risk 
scoring tools, Honest et al. (2004) concluded that there is a wide range of accuracy 
in predicting spontaneous PTB before 37 weeks.21 Risk screening tools are more 
discriminating for multigravid women given the importance of past reproductive 
characteristics on the risk of PTB.21,25 The review also noted that the evidence was 
of relatively poor quality.  
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Aside from the Creasy risk scoring system, others have not been evaluated 
outside the populations in which they were developed nor evaluated prospectively.21 
Further, few studies have specifically examined births prior to 34 weeks gestation 
despite the fact that most of the neonatal mortality and morbidity occurs in that range 
and risk factors may differ depending on the gestational age at which PTB occurs.21 
A recently published Cochrane review found no trials evaluating the use of 
risk scoring systems on PTB and thus concluded that the role of risk scoring 
systems in the prevention of PTB is unknown.26 More accurate tools with better 
quality information are needed that improve the identification of women at increased 
risk of PTB in clinical practice.21 To achieve this, research that studies multiple risk 
factors and evaluates risk-screening tools among large and diverse prospective 
cohorts is warranted.3,21,26  
Risk screening is intended to guide caregivers’ and women’s decision-making 
about the management of their pregnancy as well as target costly interventions to 
women at highest risk.21,26,27 The utility of a risk scoring system depends on the 
prevention and treatment options available to women identified as high risk.21 
Possible interventions that could be paired with a risk scoring tool include channeling 
high-risk women into intensive multidisciplinary care,28 individualized risk reduction 
counseling to women focusing on modifiable risk factors,22 and ensuring that the 
birth occurs in a facility with a neonatal intensive care unit.26 Medical treatments that 
could complement a risk scoring tool include prevention of a subsequent 
spontaneous PTB through progesterone administration,29 attempting to delay birth 
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through tocolytics (drugs that dampen the contractions),26 and administration of 
antenatal corticosteroids to improve neonatal outcomes.23,30 
Interconception Strategies for Preterm Birth Prevention 
Once a woman has been identified as high risk for PTB or has experienced a 
PTB, interconception care strategies can help to mitigate future risk. In a 12-step 
plan to reduce disparities in birth outcomes, Lu and colleagues’ (2010) first 
recommendation is to provide interconception care to women with prior adverse 
pregnancy outcomes.31 Although an entire package of health care and support 
services has been proposed in the interconception period,32 this dissertation focuses 
on one area—postpartum contraception to optimize interpregnancy intervals (IPIs) 
and avoid unintended pregnancies. 
Women who have experienced a PTB are at higher risk for having a 
subsequent preterm birth.33–35 In the Preterm Birth Prediction Study, there was a 2.5-
fold increase in the risk of spontaneous preterm delivery among women with a prior 
spontaneous delivery, particularly those occurring before 28 weeks gestation, 
compared to women with no prior spontaneous delivery.36 Black women have been 
shown to have a higher recurrence of preterm delivery as compared to white 
women.37 Little is known about the specific health-related conditions and behaviors 
that account for this increased risk.38 
Two interconception care strategies to reduce PTB are increasing 
interpregnancy intervals and avoiding unintended pregnancies, particularly among 
women who have experienced a previous PTB.39 A short interval between 
pregnancies is associated with an increased risk of PTB.40–46 Infants conceived less 
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than six months following a live birth had an odds ratio of 1.4 (95% CI 1.3–1.5) for 
PTB as compared to those conceived 18 to 23 months after a live birth.46 These 
findings, that a birth interval of 18 to 23 months is protective, have been documented 
among both black and white women.44,47 Furthermore, short IPIs are also associated 
with an increased risk of recurrent PTB among women who experienced a previous 
PTB. 48 DeFranco et al. (2007) found that as the IPI decreased, the risk of recurrent 
PTB after adjusting for other important risk factors increased.48 
In the United States, nearly half of all pregnancies are unintended.49 Women 
whose pregnancies are unintended are more likely to deliver preterm.50,51 This 
finding has not been consistent among studies, however. For instance, in one study, 
the risk of preterm birth was increased among unintended pregnancies for white and 
immigrant Latina women but not for black or U.S.-born Latina women.52 It is also not 
clear whether this is a causal association or whether the finding reflects residual 
confounding based on differences in sociodemographics and health behaviors of 
women who have unintended versus intended pregnancies.50 
Given the increased risks associated with a history of PTB, short IPIs, and 
unintended pregnancy, it is recommended that women wait at least 12 months 
between delivery and subsequent conception, particularly those with a previous 
PTB.48 To successfully space births and to avoid unintended pregnancies, women 
need access to contraception in the postpartum period. However, data on 
postpartum contraceptive practices among women with a previous PTB are 
lacking.38  
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To our knowledge only one study has specifically examined postpartum 
contraception use among women with a recent PTB.38 In this community-based 
randomized control trial, the Philadelphia Collaborative Preterm Prevention Project, 
women with a recent delivery of a living singleton infant at fewer than 35 weeks of 
gestation were followed at 6 months postpartum to assess the relationship between 
their desire to prevent or delay subsequent pregnancies and the effectiveness of 
their contraceptive use. Over half of the 658 women who participated in the six-
month assessment wanted to delay a pregnancy but reported using contraceptive 
methods classified as low or moderate in effectiveness, such as withdrawal or no 
method at all.38 However the reasons why so many expressed wanting to delay 
pregnancy but did not use a more effective method of contraception are unknown. 
The only variable that significantly predicted the use of a less effective contraceptive 
method among women wanting to delay pregnancy was low education.38 
Despite the contribution this study makes to the dearth of research on 
postpartum contraception among women at high risk for PTB, the sample, which 
was part of a randomized control trial, was young and selective with only half of trial 
participants being retained at the six-month assessment.38 Thus the generalizability 
of these findings to a broader population of women experiencing a recent PTB is 
questionable. More generalizable research on postpartum contraception use among 
women with a prior PTB is warranted to inform strategies to optimize pregnancy 
intervals and avoid unintended pregnancies, thereby reducing recurrent PTB risk.  
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STUDY OVERVIEW 
This dissertation analyzes risk screening data collected from a retrospective 
cohort of pregnant women with Medicaid coverage during pregnancy who delivered 
a live birth in North Carolina between September 2011 and September 2012. The 
purpose of this dissertation is to develop and validate a risk scoring model for PTB 
based on risk factors from the PMH risk screening tool among women screened 
early in pregnancy to more effectively identify and target women at highest risk for 
PTB for care management. In Chapter 2, the combination of risk factors most 
predictive for different groups of women by parity and race-ethnicity is presented. In 
Chapter 3, receipt of postpartum contraception and method type are compared 
between women who delivered preterm and those who delivered full term to inform 
interconception strategies for the prevention of PTB.  
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CHAPTER 2. PREDICTING PRETERM BIRTH AMONG PARTICIPANTS OF 
NORTH CAROLINA’S PREGNANCY MEDICAL HOME PROGRAM 
INTRODUCTION 
In 2012, the National Center for Health Statistics (NCHS) calculated that 
12.0% of births in North Carolina were preterm, higher than the national average of 
11.6%.4 Racial/ethnic disparities in PTB have persisted for generations with non-
Hispanic black (NHB) women having the highest rate (16%).4,18 In NC, the PTB rate 
is higher among births covered by Medicaid.53 The concentration of PTB in 
populations of lower socioeconomic status places a burden on publicly financed 
health care.19 
In response to high rates of PTB in NC, Community Care of North Carolina 
(CCNC) launched the Pregnancy Medical Home (PMH) contract in partnership with 
the North Carolina Division of Medical Assistance (DMA) in 2011. CCNC, a not-for-
profit organization, manages the care of Medicaid recipients statewide. The PMH 
program seeks to provide evidence-based, high-quality maternity care to improve 
birth outcomes in the pregnant Medicaid population.54 Eighty-five percent of all NC 
prenatal care providers (over 380 practices and clinics) serve as PMHs, including 
obstetricians, family physicians, federally qualified health centers, rural health clinics, 
local health departments, and nurse midwives.55,56 
Patients at highest risk of preterm birth are identified through a standardized risk 
screening administered at the first prenatal visit and are referred for pregnancy care 
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management to address modifiable risk factors. Risk screening is intended to target 
care management services to women at highest risk and guide caregivers’ and 
women’s decision-making about the management of their pregnancy.21,26,27 As a 
result of screening, local health departments working in partnership with CCNC 
networks provide pregnancy care management services to women. The level of 
service provided is in proportion to the individual’s identified needs. Care managers 
closely monitor the pregnancy through regular contact with the physician and patient 
to promote a healthy birth outcome. Additionally, eligible women with a history of 
spontaneous PTB or preterm rupture of the membranes who are currently pregnant 
with a singleton are offered 17alpha hydroxyprogesterone (17p). Pregnancy care 
management services continue through the postpartum period, which is defined by 
Medicaid as ending on the last day of the month in which the sixtieth postpartum day 
occurs. 
The risk screening tool includes over 40 demographic, psychosocial, current 
pregnancy, and obstetric history risk factors. About 10 conditions are considered 
priority risk factors and will automatically trigger an assessment by a pregnancy care 
manager.56 Priority risk factors include:  
 current or recent tobacco or substance use;  
 unsafe living environment (e.g., homelessness, inadequate 
housing, intimate partner violence, sexual abuse);  
 presence of chronic disease (e.g., diabetes, hypertension, human 
immunodeficiency virus, systemic lupus erythematosus, mental 
illness);  
 fetal complication (fetal anomaly, fetal chromosomal abnormality, 
intrauterine growth restriction, oligohydramnios, polyhydramnios, 
and others);  
 multi-fetal gestation;  
 previous PTB or low birth weight (LBW) baby;  
 delayed or inconsistent prenatal care; and  
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 hospitalization or emergency department use during pregnancy.  
 
The healthcare provider can also check a box to request pregnancy care 
management.  
The priority risk factors were chosen based on evidence reviewed by a 
multidisciplinary workgroup. The goal was to identify risk factors with the strongest 
associations with PTB, with consideration given to modifiable factors that drive 
increased use of the healthcare system and could be addressed through care 
management.  
It was anticipated that the risk screening would prioritize about half of 
pregnant Medicaid beneficiaries for care management. However, in practice the 
screening tool is not as specific as intended. Between January and June 2012, more 
than 75% of pregnant Medicaid patients (20,288) were screened, of which two-thirds 
had a least one priority risk factor.56 Under the current prioritization scheme, the 
priority population exceeds the capacity of the pregnancy care management 
program. Furthermore, it is not known whether the current priority risk factors are 
identifying those women at highest risk for PTB.  
The purpose of this analysis is to determine which combination of risk factors 
from the PMH screening tool best predicts PTB among women who entered care 
early enough to benefit from the care management intervention. To better target 
specific high-risk populations, we will examine whether certain risk factors are more 
predictive by parity and race/ethnicity. Analysis of the PMH risk screening tool linked 
to birth certificate data provides a unique opportunity to evaluate new and detailed 
clinical risk factor data not typically available for a large and diverse sample of 
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women with Medicaid identified early in pregnancy. Information gained through this 
evaluation will help better target resources to those most likely to benefit from 
intervention and tailor care management to specific risk profiles. 
METHODS 
Data Source 
We conducted a retrospective cohort analysis using data from CCNC’s Case 
Management Information System (CMIS), Medicaid claims, and birth certificates. 
Birth certificate data are matched to Medicaid delivery claims in the Division of 
Medical Assistance (DMA) data warehouse using Structured Query Language (SQL) 
Server Integration Services Fuzzy Lookup component software, producing a match 
rate of 95%.  
The risk screening is administered at the first prenatal visit (median of 13 
weeks gestation) and is entered into CMIS. The provider collects a medical history 
and checks a box for the presence of a risk factor. Psychosocial questions like 
pregnancy intention are self-administered in English, Spanish, or Russian, or may be 
completed through a patient interview. Risk screening forms must be provided within 
7 days of completion to the pregnancy care manager, who in turn must conduct an 
assessment within 30 days. Providers may rescreen the patient at any time during 
the pregnancy if high-risk conditions are suspected.  
To link to risk screening data during the gestational period for the index 
delivery, the obstetric estimate (OE) of gestation from the birth certificate was 
subtracted from the infant’s date of birth to calculate the mother’s last menstrual 
period (LMP) date. The risk screening with the earliest date conducted during the 
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gestational period was linked to the index birth via the mother’s Medicaid 
identification number (ID). 
All women with a valid risk screening collected between August 31, 2011, and 
May 20, 2012, and with a corresponding delivery between September 1, 2011, and 
September 30, 2012, were eligible for this analysis (n=22,612). Women were 
excluded if they were screened before 6 weeks or at or after 24 weeks gestation 
(n=6,002), if they had only Emergency Medicaid (n=7), or had a live birth prior to 24 
weeks gestation (n=62). Additionally, women missing data on risk factors from the 
screening that could not be substituted with birth certificate data were excluded 
(n=1,093, or 6.6%). The final sample size was 15,428 women (Figure 2.1). 
All study procedures were reviewed and approved by the Institutional Review 
Board for the Protection of Human Subjects at the University of North Carolina at 
Chapel Hill.  
Measures 
Preterm birth (less than 37 weeks completed gestation) was defined using the 
OE of gestation from the birth certificate. This method differs from the NCHS 
calculation based on last menstrual period.57 We evaluated all of the risk factors 
collected on the PMH Risk Screening tool in relation to PTB and grouped them as 
follows: psychosocial, current pregnancy, obstetric history, and sociodemographic 
and program characteristics. Risk factors were dichotomous (yes/no) unless 
otherwise noted. 
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 Psychosocial Characteristics 
Pregnancy intention was collapsed into three categories: intended (wanted to 
be pregnant sooner/now) [referent], unintended (wanted to be pregnant later/did not 
want to be pregnant then or any time in future), or don’t know. Missing information 
on smoking (2%) was substituted with values from the birth certificate (kappa for 
non-missing 3-category smoking 0.69). Smoking was a 4-part categorical variable: 
never or <100 cigarettes ever [referent], stopped smoking before found out was 
pregnant, stopped smoking after found out was pregnant, and smoke now but cut 
down, or smoke same amount since found out was pregnant. Questions on whether 
the participant’s parent, friend, and/or partner had a problem with alcohol or other 
drug use were combined into one substance abuse variable equal to one if any 
member had a substance problem. Questions assessing drug and alcohol use 
before pregnancy and in the past month were dichotomized as any (rarely, 
sometimes, or frequently) [referent] vs. none.  
 Current Pregnancy Characteristics 
 Delayed prenatal care was defined as initiation after 14 weeks gestation. A 
short IPI was fewer than 12 months between the last live birth and current 
pregnancy. Recurrent urinary tract infections was defined as more than two in the 
past six months or more than five in the past two years. Communication barrier 
included participants with a disability, literacy issues, or non-English speakers. 
Hypertensive disorders of pregnancy included eclampsia, preeclampsia, gestational 
hypertension, and HELLP syndrome. About 18% of women were missing BMI on the 
risk screening; these data were substituted with BMI calculated from birth certificates 
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(kappa for non-missing 4-category BMI 0.78) and categorized into four groups: 
underweight (<18.5), normal (18.5-24.9) [referent], overweight (25.0-29.9), or obese 
(>30).  
 Obstetric History 
For multivariate modeling, fetal death (>20 weeks) and second trimester 
pregnancy loss were combined into one variable, as was a history of cervical 
insufficiency and cervical insufficiency in the current pregnancy.  
 Sociodemographic and Program Characteristics  
We used several measures from birth certificates and Medicaid claims 
including maternal age, race/ethnicity, parity, and Medicaid program status. Age at 
delivery was calculated by subtracting the mother’s date of birth in Medicaid claims 
from the delivery date on birth certificates and categorized as <18, 19–34 [referent] 
and >35. Race/ethnicity from the birth certificate was categorized as non-Hispanic 
white [referent], non-Hispanic Black, Asian/Pacific Islander, American Indian/Alaska 
Native, and Hispanic. Multiple or “other” race participants were reassigned in the 
following priority: Hispanic, Black, Asian/Pacific Islander, and American 
Indian/Alaska Native. Parity from the birth certificate was calculated by adding the 
number of live births now living and now dead and dichotomized as nulliparous vs. 
parous [referent]. Medicaid program status was collapsed into Medicaid for Pregnant 
Women or any other category of Medicaid. Additional information about the 
participant’s PMH program involvement came from CMIS, including whether or not 
she received care management or 17p treatment.  
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Analysis 
Descriptive statistics and bivariate analyses (including Pearson’s chi-square 
tests) were used to compare the distributions of all the risk factors from the risk 
screening tool and PTB. We examined crude associations between risk factors and 
PTB using logistic regression. Any risk factor from the risk screening 
(sociodemographic, psychosocial, current pregnancy, and obstetric history 
characteristics) that was significant at the p<0.05 level in the Pearson’s chi-square 
tests or in the crude logistic regression model was included in the first full model. 
Backwards stepwise elimination was used to determine the optimal combination of 
risk factors for PTB, eliminating variables with a p-value greater than 0.05. All 
analyses were conducted using Stata version 13.0 (StataCorp. 2013. Stata 
Statistical Software: Release 13. College Station, TX: StataCorp LP.) 
To obtain an unbiased internal assessment of the predictive performance of 
the final model in the full sample, we used bootstrapping.58,59 After fitting the model 
in the original dataset, we conducted backwards stepwise deletion in 1,000 
bootstrap samples with replacement from the original sample and present bias-
corrected (BC) confidence intervals (CIs) from the bootstrap results.  
To test whether particular risk factors were predictive for different groups, we 
conducted stratified analysis and tested for interaction by parity (nulliparous vs. 
parous) and race/ethnicity (non-Hispanic black and non-Hispanic white). Covariates 
were included as effect measure modifiers in the adjusted interaction models if the 
Wald p-value was less than 0.05, there were sufficient observations in each cell (n > 
10), and there was evidence of heterogeneity in the stratified analysis (either the 
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confidence intervals for each level of the potential modifier did not overlap or they 
overlapped but neither included the other point estimate). For the race/ethnicity 
interaction model, we excluded Hispanic (n=1,243), Asian/Pacific Islander (n=383), 
and American Indian/Alaska Native (n=436) participants due to small cell sizes and 
based on our interest in disparities between non-Hispanic black (NHB) and non-
Hispanic white (NHW) women. 
We calculated the predicted probability of PTB for each woman using the 
linear predictor from the final model. We used receiver operating characteristic 
(ROC) curve analyses to determine the high-risk threshold for PTB at the point on 
the curve where the sum of sensitivity and specificity was highest. Using this cutoff, 
we calculated measures of model performance such as the sensitivity, specificity, 
and positive and negative predicted values. 
Additionally, we conducted several sensitivity analyses. We compared sample 
characteristics to the population of live births occurring in NC during this same time 
frame. To examine whether the intervention affected associations between risk 
factors and PTB, we compared model selection in the full sample to women who did 
not receive care management and women who did not receive 17p treatment. To 
examine how sensitive model selection was to our definition of PTB, we examined 
stricter classifications of <32 and <34 weeks completed gestation given that the bulk 
of mortality and morbidity occur in earlier gestational ages and there may be 
different physiological mechanisms involved according to the timing of PTB.  
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RESULTS 
Sociodemographic and Program Characteristics  
The prevalence of PTB was 11.0% (Table 2.1), higher than the rate we 
calculated among all resident live births in NC during the same time period (10.1%), 
even with the additional 0.4% of births at less than 24 weeks that were excluded 
from our sample. Compared to all resident live births in NC from September 2011–
September 2012, our Medicaid sample screened before 24 weeks gestation was 
younger, less educated, less likely to be married, and more likely to be NHB or 
American Indian/Alaska Native and less likely to be NHW or Hispanic. Also, women 
in our sample were more likely to smoke, be underweight or obese, and be 
nulliparous.  
Preterm birth was more frequent among NHB women, those 35 years or 
older, unmarried women and women born in the United States (Table 2.1). Women 
who screened positive for one or more priority risk factors and received care 
management (61%) had a higher prevalence of PTB than women who were not care 
managed. Administration of 17p was documented in only 2% of the sample; 23% of 
those women had a PTB.  
Psychosocial Characteristics  
Table 2.2 displays the frequency of experiencing a PTB by current pregnancy 
characteristics. Women who answered “don’t know” about their pregnancy intention, 
whose living situation was unsafe or unstable, or who used drugs or alcohol in the 
past month of pregnancy had a higher prevalence of PTB. Over 20% of women 
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continued to smoke after they found out they were pregnant, and among them, the 
PTB prevalence was 13%. 
Current Pregnancy Characteristics  
Table 2.3 displays current pregnancy characteristics including chronic 
diseases and other conditions that affected the current pregnancy. A high 
percentage of births with multi-fetal gestation, fetal complications, and cervical 
insufficiency resulted in a PTB. Nearly 17% of women had a chronic condition. 
Among the chronic diseases assessed, women with diabetes, hypertension, asthma, 
renal disease, and other chronic conditions (e.g., thyroid disease and anemia) had a 
higher prevalence of PTB. Women with hypertensive disorders had a higher 
prevalence of PTB. Fifteen percent of women had providers who requested an 
assessment and these women had a higher prevalence of PTB than women whose 
providers did not request an assessment. 
Obstetric History Characteristics  
The prevalence of prior adverse pregnancy outcomes ranged from 0.3% for a 
history of cervical insufficiency to 7.5% for a previous PTB. All of the obstetric history 
variables assessed affected prevalence of PTB (Table 2.4) with the exception of 
postpartum depression.  
Tables 2.5 and 2.6 show the crude odds ratios and 95% confidence intervals. 
Older and NHB women had higher odds of PTB. Among the psychosocial risk 
factors, answering “don’t know” about their pregnancy intention, unsafe or unstable 
housing, continued smoking during pregnancy, past substance abuse, and alcohol 
or drug use in the past month were statistically significant predictors of PTB. 
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Women with multi-fetal gestation, fetal complications, chronic disease, or 
cervical insufficiency all had elevated odds ratios for PTB, as did women whose 
provider requested that they receive a pregnancy care assessment (Table 2.6). 
Underweight and obese women also had an increased risk of PTB. Women who 
obtained late prenatal care, had a communication barrier, or were having their first 
pregnancy had reduced odds of PTB. All prior adverse pregnancy outcomes were 
associated with elevated odds of PTB with the exception of postpartum depression. 
Predictive Model of Preterm Birth 
The final predictive model in the full sample included 15 variables (Table 2.7). 
Bias-corrected confidence intervals from model selection generated using 1,000 
bootstrap replications are presented in Table 2.7 and are similar to 95% CIs in the 
original sample. Individual dummy variables that were not significant but part of a 
variable that was a significant predictor were also included in the model. Non-
Hispanic black race (OR=1.40, BC 95% CI: 1.25, 1.56) continued to be a statistically 
significant predictor of PTB once a variety of psychosocial, current pregnancy, and 
obstetric history risk factors were included. The only psychosocial risk factor that 
remained in the final model was continuing to smoke throughout pregnancy 
(OR=1.37, BC 95% CI: 1.21, 1.57), but those who quit after finding out they were 
pregnant were not at increased risk. Among current pregnancy characteristics, 
underweight remained a statistically significant risk factor, however obesity was no 
longer associated with an elevated risk of PTB.  
Of the chronic diseases, diabetes, hypertension, asthma, renal disease, and 
“other” remained in the final model. Nulliparous women had 1.20 times the odds of 
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PTB as parous women (BC 95% CI: 1.06, 1.33) when adverse reproductive history 
variables were included in the model. Among the adverse obstetric history risk 
factors, a history of PTB, delivering a LBW infant, and fetal death/second trimester 
loss remained statistically significant at p<0.05. Additionally, for each risk factor that 
was included in the first full model before backwards stepwise selection, we present 
the bootstrap inclusion fractions, or the percent of bootstrap samples in which each 
risk factor appeared (Table 2.8).  
Parity and Race/Ethnicity 
Two risk factors, food insecurity and BMI, had associations with PTB that 
differed by parity (Table 2.9). Parous women had an elevated risk of PTB associated 
with food insecurity (OR = 1.41, 95% CI: 1.04, 1.91) but nulliparous women did not 
(OR = 0.81, 95% CI: 0.58, 1.13). As previously documented, obesity was associated 
with a higher risk of PTB among nulliparous women only (OR for obese = 1.31, 95% 
CI: 1.07, 1.59),60–62 while obesity appeared protective for PTB among parous women 
(OR = 0.74, 95% CI: 0.62, 0.87).  
Two risk factors varied by race/ethnicity. Unsafe or unstable housing was 
associated with an increased risk of PTB among NHW women (OR = 1.46, 95% CI: 
1.06, 2.02) but not NHB women (Table 2.10). An interpregnancy interval (IPI) of less 
than 12 months was associated with an increased risk of PTB birth among NHB 
women only (OR =1.39, 95% CI: 1.02, 1.88).  
Table 2.11 compares risk factors currently prioritized by the PMH program to 
risk factors in our final model in the full sample and those significant among 
subgroups. Approximately half of the PMH program’s prioritized risk factors 
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remained in our models (Table 2.11, column B). Several risk factors that remained in 
the final model and interaction analyses are not prioritized by the program (Table 
2.11, column C). Several more that are prioritized by the PMH program did not 
remain in the final model or subgroup analyses (quitting smoking once finding out 
about pregnancy, current or recent drug or alcohol use, intimate partner violence, 
sexual abuse, HIV, SLE, seizure disorder, mental illness, and fetal complications) 
(Table 2.11, column D).  
Test Characteristics 
The ROC of the final model was 0.66 (Figure 2.2). The point on the curve that 
optimized both sensitivity and specificity was a predicted probability of 0.11. Using 
0.11 or higher as our risk cutoff, 22% of women screened positive. The sensitivity 
was 44%, specificity 81%, positive predictive value 22%, and negative predictive 
value 92% (Table 12). Seventy-six percent were correctly classified. However, this 
risk cutoff is quite restrictive and refers fewer women for care management than the 
program has resources to serve. For most risk factors, it would take several in 
combination to reach this threshold. Furthermore, the percent of women who screen 
negative and go on to have a PTB is 56% according to a 0.11 cutoff. A lower cutoff 
of 0.085 fits the program’s capacity to intervene with half of women. Although the 
specificity and PPV are reduced, fewer women who go on to have a PTB are missed 
(false negative rate is 29%).  
The ROC for our model with interaction terms for parity and race/ethnicity was 
slightly improved (0.67). Formal test of the equality of the ROC curves showed that 
this improvement was statistically significant (p<0.05). Finally, for comparison to the 
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PMH program’s current prioritization scheme, we calculated test characteristics 
based on the number of women having at least one priority risk factor. The ROC was 
lower (0.64, p <0.0001). The test characteristics demonstrated the poorer 
performance, with the exception of sensitivity and the false negative rate for true 
PTB, of the current prioritization scheme in which every risk factor is weighted the 
same and 71% of women screen positive. 
Sensitivity Analyses 
We compared model selection in the full sample with women who did not 
receive care management (n=6,081). Given the smaller sample size, most measures 
were stronger in magnitude and less precise (Figure 2.3). All variables from the final 
model in the full sample remained statistically significant predictors of PTB at p<0.05 
except smoking, underweight, asthma, renal disease, and LBW. Next we excluded 
women who received 17p treatment (n=339), and model selection yielded results 
similar to the full sample except that LBW and “other” chronic conditions fell out of 
the model and current pregnancy hypertensive disorders and pregnancy intentions 
remained in the model (Figure 2.4).  
We examined stricter definitions of PTB (<32 and <34 weeks). Narrowing the 
gestational age window resulted in fewer factors that were significant predictors 
(Figure 2.5). When PTB was defined as less than 32 weeks, underweight, asthma, 
renal disease, and “other” chronic conditions fell out of the model. For PTB less than 
34 weeks, underweight, asthma, renal and “other” chronic conditions were no longer 
significant predictors at p<0.05.  
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DISCUSSION 
We evaluated the PMH risk screening tool to determine the optimal 
combination of risk factors most predictive of PTB and internally validated our 
predictive model among a large and diverse cohort of women screened early in 
pregnancy. The final predictive model included: non-Hispanic black race, continuing 
to smoke during pregnancy, underweight, multi-fetal gestation, chronic diseases 
(diabetes, hypertension, asthma, renal disease, and other), cervical insufficiency, 
nulliparity, and a history of PTB, LBW, and fetal death/second trimester loss. To 
provide care management to those at greatest risk and reduce PTB rates and 
associated costs, the PMH program should target resources to women with these 
risk factors.  
Our final predictive model improves on the current PMH prioritization scheme, 
which weights all priority risk factors equally and screens in 70% of women. The 
specificity and PPV of our final predictive model are higher than those of the priority 
risk factor model (specificity: 81% vs. 31% and PPV: 22% vs. 12%). The sensitivity 
of our final model is lower than the priority risk factor model (44% vs. 79%), but 
comparable to the sensitivity of other risk scoring systems, typically below 40%.24,25, 
28,30,63–65 However, comparison across studies is hampered by differing outcome 
definitions, by mode of delivery (spontaneous vs. all), and by gestational age (early 
PTB <32 vs. <37 weeks), as well as different PTB prevalence and scores for a 
positive test. 
Previous research suggests that inclusion of endemic risks to specific 
populations may improve the validity of screening tools.28 Therefore we tested for 
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interaction by parity (because risk scoring tools are more discriminating for 
multigravida women given the importance of obstetric history)21,25 and by 
race/ethnicity. Addition of variables that were highly predictive of PTB among certain 
subgroups (food insecurity, obesity, unsafe or unstable housing, and short IPIs) 
slightly improved the predictive ability of the model. The PMH program should 
consider including these as priority risk factors given their importance among 
vulnerable subgroups, particularly nulliparous and NHB women.  
Based on our final model in the full sample and our interaction analyses, we 
have several recommendations for revising the risk screen. First, variables currently 
prioritized that remained in our final model should continue to be prioritized (current 
smoking, diabetes, hypertension, asthma, renal disease, other chronic conditions, 
multi-fetal gestation, and previous PTB and LBW) (Table 2.11, column B). Given the 
current tool’s lower sensitivity and PPV, which refers any woman for assessment 
with at least one priority risk factor and counts all factors equally, applying weights to 
the risk factors based on the odds ratios from the final model could increase the 
predictive value of the tool by decreasing the prevalence of a positive test.  
Second, to direct resources where they are most needed, some priority risk 
factors that did not remain in the final model should be deprioritized (Table 2.11, 
column D). For instance, 17% of women stopped smoking once they found out they 
were pregnant and were care managed despite the fact that their risk of PTB was 
not substantively higher than women who quit before pregnancy or never smoked. 
Forty-four percent (n=1,178) of these women do not have any other priority risk 
factors; thus, deprioritizing women who quit smoking would enable care managers to 
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focus on higher-risk women. Delayed prenatal care could be dropped as a priority 
risk factor because this had an inverse relationship with PTB, likely due to the 
increased likelihood of women entering care late to be younger, Hispanic, foreign-
born, and less likely to have had a previous adverse outcome or carry multiples. This 
would remove 1,148 women who had no other priority risk factor. Among the 1,148 
that would no longer be eligible for care management, 181 cases of PTB would be 
missed. Before risk factors are removed from the priority list, it will be important to 
verify through similar analyses that these factors are not highly predictive of other 
important maternal and child outcomes that the program aims to impact.  
Third, consideration should be given to adding several risk factors that 
remained in the final models but are not currently prioritized (Table 2.11, column C). 
Adding underweight (n=703, 5%), cervical insufficiency (n=102, 1%), and fetal 
death/second trimester loss (n=317, 2%) is advisable because they are likely to 
increase the predictive value of the tool. Additionally, some of these risk factors are 
amenable to intervention, which is an important consideration for the PMH program. 
In all, 1,122 high-risk women would be added, a net reduction of 1,204 women. 
Two additional risk factors not currently prioritized by the program, nulliparity 
and NHB race, remained significant in our final model (Table 2.11, Column C). 
Questions remain whether these risk factors can be modified by care management 
given our limited knowledge of the mechanisms placing these women at higher risk 
and whether or not the PMH program has the resources to care manage such a 
large proportion of the population, many of whom do not have any other priority risk 
factor.  
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We sought to identify risk factors that would be amenable to intervention 
within these groups. Eleven percent (n=1,792) of nulliparous women were obese, of 
which 31% had no other priority risk factor. Given the increased risk of PTB among 
obese nulliparous women, intervening on obesity may be one strategy to focus 
resources on a subgroup of nulliparous women more likely to benefit from 
intervention.  
Only one risk factor, a short interpregnancy interval, increased the odds of 
PTB differentially for NHB women. About 6% or 353 NHB women had a short IPI, of 
which 25% had no other priority risk factor. Previous studies have shown that black 
women are 1.8 times more likely to have short IPIs compared to whites, particularly 
intervals less than six months.40,45,66,67 Our findings are consistent with the 
“weathering hypothesis,” that poorer overall health among black women in the 
United States contributes to their greater burden of PTB.11 Perhaps a short interval 
between pregnancies compounds the risk for black women who may have poorer 
health over the life course.12  
NHB women who had short intervals were more likely to report their 
pregnancy as unintended compared to other women with short intervals in our 
sample (69% vs. 56%). However, the odds of PTB associated with a short IPI 
among NHB women remained elevated when we controlled for pregnancy intention 
and other potential confounders like age, parity, education, marital status, chronic 
diseases, and previous adverse outcomes (OR = 1.37; 95% CI: 1.00, 1.87) (results 
not shown).  
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Interaction between short IPI and race has been tested in previous studies 
but not supported,40,47,66,67 with the exception of one study among military women in 
which Rawlings et al. (1995) documented higher PTB rates among intervals less 
than nine months for blacks.45,66 Differing results between our findings and those 
lacking interaction could be because our measure of short IPI (<12 months) is based 
on physician report versus vital or medical records. Additionally, we include women 
of higher parity whereas other studies included first and second births only.66 In our 
sample, NHB women were more likely to have short IPIs among higher-order births 
(parity >2) than NHW women (55% NHB vs. 48% NHW).  
Unfortunately no other risk factors assessed explained the increased risk 
among NHB women, as has been observed in previous studies.9 The risk screening 
tool does not assess factors such as racism, discrimination, stress, and unequal 
access to opportunities or resources from which disparities originate.13,68 Prioritizing 
all NHB women for care management may be the best starting point toward 
eliminating this gap among pregnant women on Medicaid in NC. Although reducing 
the risk of short IPIs among black women is one way to reduce disparities in PTB,66 
there is some evidence that social support and care coordination in the prenatal and 
interconception period could potentially reduce rates of poor birth outcomes among 
black women.69–72 Primary health care and social support for low-income black 
women in Georgia following an adverse reproductive outcome helped achieve longer 
IPIs and fewer subsequent adverse pregnancy outcomes.69 If care management is 
offered to all black women and decreases in PTB are documented, future research 
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could determine which aspects of care management are most influential and provide 
insight into closing the gap in racial/ethnic disparities in birth outcomes.  
Although psychosocial factors (aside from smoking) were not significant 
among the full sample, we found two factors that were predictive of PTB among 
subgroups—food insecurity and housing. Food insecurity, defined as being hungry 
from not being able to eat or being unable to afford food in the past 12 months, was 
a significant predictor of PTB among parous women only. To our knowledge, this is 
a new finding, perhaps because our assessment does not account for household 
size like other measures of food insecurity. We hypothesize that this finding captures 
the stress associated with having food insecurity in the context of providing for a 
family compared to food insecurity among nulliparous women without other children 
to feed. A study conducted among black and white women in central NC showed 
that perceived stress was the predominant psychosocial indicator associated with 
food insecurity, even when adjusting for demographic and other psychosocial 
variables.73  
Our study contributes to the emerging literature on the complex influences of 
the interaction of the social environment and race/ethnicity. Unsafe or unstable 
housing was associated with PTB among NHW women but not NHB women. This 
echoes previous work by Dole and colleagues (2004) in NC who found that blacks 
were more likely than whites to report low perceived neighborhood safety but had no 
increased risk associated with it.37 Also, O’Campo and colleagues (2008) found that 
neighborhood deprivation was more strongly associated with PTB for whites than 
blacks despite blacks being more likely to live in deprived areas.74,75 
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There are several limitations to this analysis. We excluded 6.6% of women 
due to missing data. Excluded women were more likely to be older, parous, non-
white, foreign-born, married, less educated, to use substances and smoke, live in 
unsafe or unstable housing, have a fetal complication, and have a provider who 
requested a care management assessment. We substituted missing values for BMI 
and smoking and used parity and race/ethnicity from the birth certificate because the 
data were more complete. Thus inferences for these risk factors are based on how 
they are reported on the birth certificate, which may differ from the risk-screening 
tool. If data collection and quality for these measures are not improved, efforts to 
identify and target women with these risk factors will be hampered. Additionally we 
were unable to examine two priority risk factors (missed two or more prenatal care 
appointments and hospital use during pregnancy) due to small numbers.  
Numbers for current pregnancy characteristics were low for conditions that 
are often not detected until later in the pregnancy such as hypertensive disorders of 
pregnancy, likely due to our screening cutoff prior to 24 weeks. Another possible 
explanation is that current pregnancy and obstetric history variables are assessed by 
a single check box (rather than yes/no), thus it is possible the provider neglected to 
check a condition that was present. Instead of being counted as missing, it was 
counted as an absence of the condition. This could lead to a lower prevalence of 
these factors and an underestimation of the effects. For example, hypertensive 
disorders in the current pregnancy showed evidence of interaction with parity such 
that nulliparous women had elevated odds of PTB associated with it. However, due 
to small cell sizes (n<5), we did not include it in the final models. Still, it warrants 
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reexamination among women screened later in pregnancy. We compared the 
prevalence of chronic conditions on the risk screening to those from birth certificates 
in our sample and the prevalence on the risk screen was higher. For example, the 
prevalence of chronic diabetes and hypertension was 1.47% and 2.90% from the 
risk screen and 0.97% and 2.26% from the birth certificate. This suggests that 
chronic disease reporting on the risk screen may be more complete than the birth 
certificate.  
We chose a 24-week cutoff because we wanted to ensure that measurement 
of exposures occurred before the outcome and to identify risk factors that were 
predictive of PTB among women who entered care early enough to benefit from the 
care management intervention. Thus the final predictive model may not capture risk 
factors that are predictive of PTB among women screened later in pregnancy. We 
examined the selectivity of our sample by comparing sample characteristics to those 
of women screened after 24 weeks of completed gestation. Nearly three-fourths of 
women were screened prior to 24 weeks and 79% of PTBs occurred to them. 
Women screened after 24 weeks were more likely to be Hispanic, foreign-born, 
report an unintended pregnancy, and have a previous live birth. They were less 
likely to be NHB, to smoke or abuse substances, or to have had a previous adverse 
reproductive outcome. By excluding women screened at 24 weeks or beyond, we 
were more likely to miss lower-risk women. If we had not excluded these women, the 
prevalence of PTB would be 10.93% instead of 11.01%.  
Over 60% of women included in our analysis received care management 
versus usual care based on having one or more priority risk factors. The program’s 
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care management activities could potentially reduce the association between risk 
factors and PTB, biasing our predictive model.28 For example, women with a prior 
spontaneous PTB are at higher risk for a subsequent PTB, but through the PMH 
program, 2% were documented as receiving progesterone (17p) treatment, which 
could underestimate the effect of prior PTB.22 In an attempt to reduce potential 
intervention effects, we conducted our analysis among women screened at program 
inception in 2011. Our sensitivity analyses showed slight changes in selected 
variables for the final model when women receiving care management and 17p 
treatment were removed, likely due to the smaller sample size.  
 Finally, obstetric estimate of gestation was used as our outcome measure. 
Several studies have examined the validity of OE since its addition to the 2003 
revision of the birth certificate and concluded that OE may undercount the rate of 
PTB.76–80 We acknowledge that OE may underestimate PTB and make our estimate 
of PTB look better than the national prevalence based on LMP calculated by NCHS, 
however, we chose to use OE because LMP was missing more observations in our 
sample and LMP has its own limitations.78,79  
Despite these limitations, our analysis provides insight into how the evidence-
based PMH program can increase the sensitivity and specificity of their tool. The 
PMH risk screen assesses many factors, several of which have never been 
assessed in previous tools, with the ability to intervene in real time to guide decision-
making about pregnancy management. Patient-specific predicted probabilities from 
our final model can be calculated for each woman screened, which is an 
improvement over the current prioritization scheme that does not weight risk factors. 
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The improved specificity can help prevent care managers from becoming 
overburdened serving too many women, which could lead to a “watering down” of 
the intervention. Based on linkage from birth certificates, Medicaid claims, and PMH 
risk screens, salient risk factors for PTB were identified for vulnerable subgroups 
that will allow for better targeted prevention approaches that could promote health 
equity in birth outcomes. At the same time, we recognize that identifying women at 
highest risk is only the first step. The utility of a risk scoring system depends on the 
prevention and treatment options available to women identified as high risk.21 More 
evidence on the ability of and mechanisms through which care management 
reduces poor birth outcomes and associated costs is needed. 
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FIGURES AND TABLES 
Figure 2.1. Analysis sample. 
 
 
  
- 49% (n=33,852) no risk screening conducted
- 2.9% (n=1,028) duplicate or inactive risk screen
- 34% (n=11,759) 1st risk screen conducted 
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- 26% (n=6,022) 1st risk screen conducted
  before 6 weeks or at or after 24 weeks
-0.04% (n=7) Emergency Medicaid
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6 and 24 weeks gestation
and May 20, 2012
No missing data
n = 15,428
Gestational age at birth > 24 weeks
n = 16,521
With Prenatal Medicaid coverage
n = 16,583
With CMIS risk screening data
n = 35,399
First screening between Aug 31, 2011
n = 22,612
First screening conducted between  
n = 16,590
One valid risk screen per 
n = 34,371
woman
matched to birth certificates
n = 69,251
All N.C. resident live births to
mothers on Medicaid
Sept. 1, 2011 - Sept. 30, 2012
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Table 2.1.  
 
Sociodemographic and Program Characteristics among Women Screened by the 
Pregnancy Medical Home Program, Stratified by Preterm Birth (n=15,428) 
 
Term Preterm 
Total 37–42 weeks 24–36 weeks 
(Col %) N % N % 
p-
value* 
Sociodemographics  
Age at Delivery 0.008
<18 (10.36) 1427 89.30 171 10.70 
19-34 (84.44) 11616 89.16 1412 10.84 
>35 (5.20) 687 85.66 115 14.34 
Race/Ethnicity 0.0001
Non-Hispanic White (46.37) 6461 90.31 693 9.69 
Non-Hispanic Black (40.26) 5402 86.96 810 13.04 
Asian/Pacific Islander (2.48) 344 89.82 39 10.18 
American Indian/Alaska 
Native (2.83) 389 89.22 47 10.78 
Hispanic (8.06) 1134 91.23 109 8.77 
U.S. Born 0.011
No (6.44) 909 91.45 85 8.55 
Yes (93.56) 12821 88.82 1613 11.18 
Married at Conception or 
Birth 0.002
No (70.92) 9682 88.48 1260 11.52 
Yes (28.99) 4035 90.23 437 9.77 
Missing (n=14) (0.09) 13 ------- 1 ------- 
Education Level 0.144
< High School (25.40) 3468 88.49 451 11.51 
High School Graduate or 
GED (35.51) 4912 89.65 567 10.35 
Some College or More (39.03) 5343 88.72 679 11.28 
Missing (n=8) (0.05) 7 ------- 1 ------- 
Program Characteristics 
Medicaid for Pregnant 
Women (MPW) 0.0001
No (34.15) 4602 87.36 666 12.64 
Yes (65.85) 9128 89.84 1032 10.16 
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Received Care Management 0.0001
No (39.42) 5522 90.81 559 9.19 
Yes (60.58) 8208 87.81 1139 12.19 
Received 17p† 0.0001
No (97.80) 13505 89.50 1584 10.50 
Yes (2.20) 225 66.37 114 33.63 
Sample Size (n) 100.00 13730 88.99 1698 11.01 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012.  
(Col %) = column percent; N = frequency; % = row percent. *p-value from the Pearson chi-square 
test calculated without missing. †Eligible women with a history of spontaneous preterm birth or 
preterm rupture of the membranes who are currently pregnant with a singleton (n = 542) are 
offered 17alpha hydroxyprogesterone (17p).
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Table 2.2.  
 
Psychosocial Characteristics among Women Screened by the Pregnancy Medical 
Home Program, Stratified by Preterm Birth (n=15,428) 
 
Term Preterm 
Total 37–42 weeks 
24–36 
weeks 
(Col 
%) N % N % p-value*
Pregnancy Intention 0.007
Intended (26.65) 3685 89.64 426 10.36 
Unintended (54.81) 7545 89.23 911 10.77 
Don't know (18.54) 2500 87.38 361 12.62 
Physical Violence (past 
year) 0.392
No (95.97) 13183 89.04 1623 10.96 
Yes (4.03) 547 87.94 75 12.06 
Intimate Partner Violence  0.296
No (99.62) 13680 89.01 1689 10.99 
Yes (0.38) 50 84.75 9 15.25 
Forced Sex (ever)  0.703
No (98.23) 13489 89.01 1666 10.99 
Yes (1.77) 241 88.28 32 11.72 
Food Insecurity (past year)  0.189
No (94.72) 13017 89.07 1597 10.93 
Yes (5.28) 713 87.59 101 12.41 
Unsafe or Unstable Housing 
No (93.80) 12900 89.14 1571 10.86 0.021
Yes (6.20) 830 86.73 127 13.27 
Smoking Status  0.0001
Never or Fewer than 100 
Cigs (50.17) 6935 89.60 805 10.40 
Stopped before Pregnancy (10.27) 1440 90.85 145 9.15 
Stopped after Pregnancy (17.17) 2365 89.28 284 10.72 
Cut down since 
Pregnancy/Smoke Same 
Amount (22.39) 2990 86.57 464 13.43 
Parent/Friend/Partner 
Substance Problem 0.839
No (77.70) 10671 89.02 1316 10.98 
Yes (22.30) 3059 88.90 382 11.10 
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Past Substance Problem  0.051
No (95.72) 13158 89.10 1610 10.90 
Yes (4.28) 572 86.67 88 13.33 
Alcohol/Drug Use before 
Pregnancy 0.344
No (45.31) 6239 89.26 751 10.74 
Yes (54.69) 7491 88.78 947 11.22 
Alcohol/Drug Use Past 
Month 0.006
No  (88.85) 12233 89.24 1475 10.76 
Yes (11.15) 1497 87.03 223 12.97 
Sample Size (n) 100.00 13730 88.99 1698 11.01 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012.  
(Col %) = column percent; N = frequency; % = row percent. *p-value from the Pearson chi-
square test 
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Table 2.3.  
 
Current Pregnancy Characteristics among Women Screened by the Pregnancy 
Medical Home Program, Stratified by Preterm Birth (n=15,428) 
 
  Term Preterm 
Total 37–42 weeks 
24–36 
weeks 
(Col 
%) N % N % 
p-
value*
Body Mass Index  0.004
Underweight (4.54) 600 85.59 101 14.41 
Normal weight (37.92) 5254 89.81 596 10.19 
Overweight (24.12) 3310 88.93 412 11.07 
Obese (33.41) 4566 88.57 589 11.43 
Multifetal Gestation  0.0001
No (99.03) 13661 89.41 1618 10.59 
Yes (0.97) 69 46.31 80 53.69 
Fetal Complication 0.015
No (99.63) 13685 89.03 1686 10.97 
Yes (0.37) 45 78.95 12 21.05 
Chronic Conditions 
Diabetes 0.0001
No (98.53) 13572 89.28 1629 10.72 
Yes (1.47) 158 69.60 69 30.40 
Hypertension 0.0001
No (97.10) 13397 89.43 1583 10.57 
Yes (2.90) 333 74.33 115 25.67 
Asthma 0.0001
No (95.18) 13103 89.23 1582 10.77 
Yes (4.82) 627 84.39 116 15.61 
Mental Illness 0.811
No (94.53) 12981 89.01 1603 10.99 
Yes (5.47) 749 88.74 95 11.26 
HIV 0.443
No (99.88) 13715 89.00 1695 11.00 
Yes (0.12) 15 83.33 3 16.67 
Seizure 0.611
No (99.16) 13617 89.01 1682 10.99 
Yes (0.84) 113 87.60 16 12.40 
Renal Disease 0.013
No (99.82) 13710 89.02 1691 10.98 
Yes (0.18) 20 74.07 7 25.93 
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Systemic Lupus 
Erythematosus 0.568
No (99.87) 13713 89.00 1695 11.00 
Yes (0.13) 17 85.00 3 15.00 
Other Chronic Condition 0.001
No (95.91) 13193 89.16 1604 10.84 
Yes (4.09) 537 85.10 94 14.90 
Current or Recent 
Drug/Alcohol Use 0.406
No (94.09) 12926 89.05 1590 10.95 
Yes (5.91) 804 88.16 108 11.84 
Delayed Prenatal Care (>14 
weeks) 0.001
No (79.65) 10883 88.57 1405 11.43 
Yes (20.35) 2847 90.67 293 9.33 
Cervical Insufficiency 0.0001
No (99.47) 13684 89.17 1662 10.83 
Yes (0.53) 46 56.10 36 43.90 
Gestational Diabetes 0.667
No (99.59) 13675 89.00 1690 11.00 
Yes (0.41) 55 87.30 8 12.70 
Vaginal Bleeding in Second 
Trimester 0.060
No (99.62) 13682 89.02 1687 10.98 
Yes (0.38) 48 81.36 11 18.64 
Hypertensive Disorders of 
Pregnancy 0.0001
No (99.28) 13644 89.08 1673 10.92 
Yes (0.72) 86 77.48 25 22.52 
Short Interpregnancy Interval (<12 
mos) 0.120
No (94.51) 12990 89.09 1591 10.91 
Yes (5.49) 740 87.37 107 12.63 
Current Sexually Transmitted 
Infection 0.158
No (97.82) 13439 89.05 1653 10.95 
Yes (2.18) 291 86.61 45 13.39 
Recurrent Urinary Tract 
Infection  0.379
No (98.86) 13577 89.02 1675 10.98 
Yes (1.14) 153 86.93 23 13.07 
Provider Requests Pregnancy 
Assessment 0.017
No (84.93) 11694 89.25 1409 10.75 
Yes (15.07) 2036 87.57 289 12.43 
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Communication Barrier 0.012
No (97.66) 13394 88.90 1673 11.10 
Yes (2.34) 336 93.07 25 6.93 
Sample Size (n) 100.00 13730 88.99 1698 11.01 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012.  
(Col %) = column percent; N = frequency; % = row percent. *p-value from the Pearson chi-square 
test 
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Table 2.4.  
 
Obstetric History Characteristics among Women Screened by the Pregnancy 
Medical Home Program, Stratified by Preterm Birth (n=15,428) 
 
Term Preterm 
Total 37–42 weeks 
24–36 
weeks 
(Col 
%) N % N % 
p-
value* 
Nulliparous 0.029
No (57.24) 7817 88.52 1014 11.48 
Yes (42.76) 5913 89.63 684 10.37 
Non-spontaneous Preterm Birth 0.0001
No (96.10) 13283 89.59 1543 10.41 
Yes (3.90) 447 74.25 155 25.75 
Spontaneous PTB or Rupture of 
Membranes  0.0001
No (96.45) 13344 89.68 1536 10.32 
Yes (3.55) 386 70.44 162 29.56 
Low Birth Weight 0.0001
No (98.11) 13514 89.28 1622 10.72 
Yes (1.89) 216 73.97 76 26.03 
Fetal Death 0.0001
No (98.81) 13601 89.22 1643 10.78 
Yes (1.19) 129 70.11 55 29.89 
Neonatal Death 0.0001
No (99.53) 13680 89.09 1675 10.91 
Yes (0.47) 50 68.49 23 31.51 
Second Trimester Pregnancy 
Loss 0.0001
No (98.94) 13611 89.17 1653 10.83 
Yes (1.06) 119 72.56 45 27.44 
Three or More First Trimester Losses  0.038
No (98.90) 13588 89.05 1671 10.95 
Yes (1.10) 142 84.02 27 15.98 
Cervical Insufficiency  0.0001
No (99.69) 13704 89.10 1676 10.90 
Yes (0.31) 26 54.17 22 45.83 
Gestational Diabetes  0.093
No (98.42) 13521 89.05 1663 10.95 
Yes (1.58) 209 85.66 35 14.34 
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Postpartum Depression  0.644
No (98.59) 13539 89.01 1672 10.99 
Yes (1.41) 191 88.02 26 11.98 
Hypertensive Disorders of Pregnancy  0.001
No (96.16) 13227 89.16 1608 10.84 
Yes (3.84) 503 84.82 90 15.18 
Sample size (n) 100.00 13730 88.99 1698 11.01 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012.  
(Col %) = column percent; N = frequency; % = row percent. *p-value from the Pearson  
chi-square test. 
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Table 2.5.  
 
Crude ORs for Sociodemographic, Program, and Psychosocial Characteristics and 
Preterm Birth among Women Screened by the Pregnancy Medical Home Program 
(n=15,428) 
 
Unadjusted 
OR (95% CI) p-value 
Sociodemographics 
Age at Delivery 
<18 years 0.99 (0.83, 1.17) 
19-34 years (ref) --- --- 
>35 years 1.38 (1.12, 1.69) *** 
Race/Ethnicity 
Non-Hispanic White (ref) --- --- 
Non-Hispanic Black 1.40 (1.26, 1.56) *** 
Asian/Pacific Islander 1.06 (0.75, 1.49) 
American Indian/Alaska Native 1.13 (0.82, 1.54) 
Hispanic 0.90 (0.73, 1.11) 
U.S. Born  1.35 (1.07, 1.69) ** 
Married at Conception or Birth 0.83 (0.74, 0.93) *** 
Education Level 
< High School 1.02 (0.90, 1.16) 
High School Graduate or GED 0.91 (0.81, 1.02) 
Some College or more (ref) --- --- 
Program Characteristics 
Medicaid for Pregnant Women (MPW) 0.78 (0.70, 0.87) *** 
Received Care Management 1.37 (1.23, 1.53) *** 
Received 17p† 4.32 (3.43, 5.44) *** 
Psychosocial Characteristics 
Pregnancy Intention 
Intended --- --- 
Unintended 1.04 (0.93, 1.18) 
Don't know 1.25 (1.08, 1.45) *** 
Physical Violence (past year) 1.11 (0.87, 1.43) 
Intimate Partner Violence  1.46 (0.72, 2.97) 
Forced Sex (ever)  1.08 (0.74, 1.56) 
Food Insecurity (past year)  1.16 (0.93, 1.43) 
Unsafe or Unstable Housing 1.26 (1.04, 1.53) ** 
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Smoking Status  
Never or Fewer than 100 Cigarettes --- --- 
Stopped before Pregnancy 0.87 (0.72, 1.04) 
Stopped after Pregnancy 1.04 (0.90, 1.19) 
Cut down since Pregnancy/Smoke Same Amount 1.34 (1.18, 1.51) *** 
Parent/Friend/Partner Substance Problem 1.01 (0.90, 1.14) 
Past Substance Problem  1.26 (1.00, 1.58) * 
Alcohol/Drug Use before Pregnancy 1.05 (0.95, 1.16) 
Alcohol/Drug Use Past Month 1.24 (1.06, 1.44) *** 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012. OR = odds 
ratio, CI = confidence interval. *p<0.1, **p<0.05, ***p<0.01 
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Table 2.6.  
 
Crude Odds Ratios for Current Pregnancy and Obstetric History Characteristics and 
Preterm Birth among Women Screened by the Pregnancy Medical Home Program 
(n=15,428) 
 
Unadjusted 
OR (95% CI) 
p - 
value 
Current Pregnancy Characteristics 
Normal weight --- --- 
Underweight 1.48 (1.18, 1.86) *** 
Overweight 1.10 (0.96, 1.25) 
Obese 1.14 (1.01, 1.28) ** 
Multifetal Gestation  9.79 (7.07, 13.56) *** 
Fetal Complication 2.16 (1.14, 4.10) ** 
Chronic Conditions 
Diabetes 3.64 (2.73, 4.85) *** 
Hypertension 2.92 (2.35, 3.64) *** 
Asthma 1.53 (1.25, 1.88) *** 
Mental Illness 1.03 (0.83, 1.28) 
HIV 1.62 (0.47, 5.60) 
Seizure 1.15 (0.68, 1.94) 
Renal Disease 2.84 (1.20, 6.72) ** 
Systemic Lupus Erythematosus 1.43 (0.42, 4.88) 
Other Chronic Condition 1.44 (1.15, 1.80) *** 
Current or Recent Drug/Alcohol Use 1.09 (0.89, 1.34) 
Delayed Prenatal Care (>14 weeks) 0.80 (0.70, 0.91) *** 
Cervical Insufficiency 6.44 (4.15, 10.00) *** 
Gestational Diabetes 1.18 (0.56, 2.48) 
Vaginal Bleeding in the Second Trimester 1.86 (0.96, 3.59) * 
Hypertensive Disorders of Pregnancy 2.37 (1.51, 3.71) 
Short Interpregnancy Interval (<12 mos) 1.18 (0.96, 1.46) 
Current Sexually Transmitted Infection 1.26 (0.92, 1.73) 
Recurrent Urinary Tract Infection 1.22 (0.78, 1.89) 
Provider Requests Pregnancy Assessment 1.18 (1.03, 1.35) ** 
Communication Barrier 0.60 (0.40, 0.90) ** 
Obstetric History 
Nulliparous 0.89 (0.81, 0.99) ** 
Non-spontaneous Preterm Birth  2.99 (2.47, 3.61) *** 
Spontaneous Preterm Birth or Rupture of 
Membranes  3.65 (3.01, 4.41) *** 
Low Birth Weight 2.93 (2.25, 3.83) *** 
Fetal Death 3.53 (2.56, 4.86) *** 
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Neonatal Death 3.76 (2.29, 6.17) *** 
Second Trimester Loss 3.11 (2.20, 4.40) *** 
Three or More First Trimester Losses  1.55 (1.02, 2.34) ** 
Cervical Insufficiency  6.92 (3.91, 12.23) *** 
Gestational Diabetes  1.36 (0.95, 1.96) * 
Postpartum Depression  1.10 (0.73, 1.67) 
Hypertensive Disorders of Pregnancy 1.47 (1.17, 1.85) *** 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012.  
OR = odds ratio, CI = confidence interval. *p<0.1, **p<0.05, ***p< 0.01
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Table 2.7.  
 
Final Predictive Model for Preterm Birth with Bias Corrected Confidence Intervals 
from Bootstrapping among Women Screened by the Pregnancy Medical Home 
Program (n=15,428) 
 
OR BC (95% CI) 
p-
value 
Characteristics 
Non-Hispanic White --- --- 
Non-Hispanic Black 1.40 (1.25, 1.56) *** 
Asian/Pacific Islander 1.20 (0.82, 1.65) 
American Indian/Alaska Native 1.10 (0.82, 1.53) 
Hispanic 1.02 (0.81, 1.24) 
Never or Fewer than 100 Cigarettes --- --- 
Stopped Smoking before Pregnancy 0.90 (0.73, 1.08) 
Stopped Smoking after Pregnancy 1.04 (0.88, 1.20) 
Cut Down since Pregnancy/Smoke Same Amount 1.37 (1.21, 1.57) *** 
Underweight 1.55 (1.21, 1.93) *** 
Normal weight --- --- 
Overweight 1.06 (0.91, 1.21) 
Obese 0.93 (0.83, 1.08) 
Multifetal Gestation 10.78 (7.66, 16.22) *** 
Chronic Diabetes 3.04 (2.20, 4.08) *** 
Chronic Hypertension 2.34 (1.82, 2.98) *** 
Asthma 1.36 (1.07, 1.68) *** 
Renal Disease 2.58 (0.81, 6.45) ** 
Other Chronic Condition 1.30 (1.00, 1.63) ** 
Cervical Insufficiency (current or history) 2.87 (1.72, 4.43) *** 
Nulliparous 1.20 (1.06, 1.33) *** 
Parous --- --- 
Non-spontaneous Preterm Birth History 2.76 (2.18, 3.39) *** 
Spontaneous Preterm Birth or Rupture of 
Membranes History 3.39 (2.71, 4.28) *** 
Low Birth Weight History 1.35 (0.97, 1.84) ** 
Fetal Death/Second Trimester Loss History 1.73 (1.24, 2.35) *** 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to September 30, 2012.  
**p< 0.05, ***p< 0.01. All variables in the model are significant at p<0.05 unless they are part of a 
group of indicators in which not all indicators are statistically significant.  
OR = odds ratio; BC = bias corrected; CI = confidence interval 
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Table. 2.8.  
 
Bootstrap Inclusion Fractions in Predicting Preterm Birth (n=1,000) 
 
Risk Factors*  N % 
<18 years 323 32.30
>35 years 323 32.30
Non-Hispanic Black 998 99.80
Hispanic 998 99.80
Asian/Pacific Islander 998 99.80
American Indian/Alaska Native 998 99.80
Unintended Pregnancy  496 49.60
Don't Know Pregnancy Intention 496 49.60
Unsafe or Unstable Housing 312 31.20
Stopped Smoking before Pregnancy 993 99.30
Stopped Smoking after Pregnancy 993 99.30
Cut Down since Pregnancy/Smoke Same Amount 993 99.30
Alcohol/Drug Use before Pregnancy 70 7.00
Alcohol/Drug Use Past Month 91 9.10
Underweight 928 92.80
Overweight 928 92.80
Obese 928 92.80
Multifetal Gestation 1000 100.00
Fetal Complication 219 21.90
Chronic Diabetes 999 99.90
Chronic Hypertension 1000 100.00
Asthma 785 78.50
Renal Disease 506 50.60
Other Chronic Condition 550 55.00
Current or Recent Drug/Alcohol Use 171 17.10
Cervical Insufficiency (current or history) 978 97.80
Hypertensive Disorders in Current Pregnancy 417 41.70
Provider Requests Assessment  375 37.50
Nulliparous 821 82.10
Non-spontaneous Preterm Birth History 1000 100.00
Spontaneous Preterm Birth or Rupture of Membranes History 1000 100.00
Low Birth Weight History 483 48.30
Fetal Death/Second Trimester Loss History 929 92.90
Neonatal Death History 329 32.90
Three or More First Trimester Losses 100 10.00
Gestational Diabetes History 55 5.50
Hypertensive Disorders of Pregnancy History 55 5.50
*All risk factors included in the comprehensive model before backwards stepwise deletion in 
the full sample (n=15,428). N= number; % = percent of 1,000 models in which the variable 
was selected. Variables in the final predictive model were selected >50% of the time with the 
exception of low birth weight history. 
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Table 2.9.  
 
Adjusted Odds Ratios for Food Insecurity and Body Mass Index on Preterm Birth 
among Women Screened by the Pregnancy Medical Home Program, Stratified by 
Parity (n=15,428) 
 
Nulliparous Parous Effects
Differ 
OR (95% CI) 
p-
value OR (95% CI) 
p-
value 
Full Sample   
Food Insecurity 0.81 (0.58, 1.13) 1.41 (1.04, 1.91) ** Yes 
Underweight 1.43 (1.01, 2.01) ** 1.73 (1.26, 2.38) *** No 
Normal weight --- --- --- --- No 
Overweight 1.20 (0.97, 1.48) 0.94 (0.79, 1.13) Yes 
Obese 1.31 (1.07, 1.59) *** 0.74 (0.62, 0.87) *** Yes 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011 to September 30, 2012. The model 
includes all variables in the main effects model. **p<0.05, ***p<0.01. Effects differ refers to 
whether the effects of food security and body mass index variables on the odds of preterm birth 
differ between nulliparous and parous women.  
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Table 2.10.  
 
Adjusted Odds Ratios for Housing and Short Interpregnancy Interval on Preterm 
Birth among Women Screened by the Pregnancy Medical Home Program, Stratified 
by Race/Ethnicity (n=13,336) 
 
  Non-Hispanic Black Non-Hispanic White Effects 
Differ 
  OR (95% CI) p OR (95% CI) p 
Black & White 
Sample 
Unsafe or Unstable 
Housing 0.88 (0.65, 1.19) 1.46 (1.06, 2.02) ** Yes 
Short Interpregnancy 
Interval (<12 mos) 1.39 (1.02, 1.88) ** 0.72 (0.49, 1.06) Yes 
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011 to September 30, 2012. The model 
includes all variables in the final predictive model. **p<0.05. Effects differ refers to whether the 
effects of housing and short interpregnancy interval on the odds of preterm birth differ between 
non-Hispanic white and non-Hispanic black women. 
 
 
 Table 2.11.  
 
Comparison of Risk Factors Prioritized by the Pregnancy Medical Home Program to Risk Factors in the Final Predictive 
Model in the Full Sample and Subgroup Analyses 
 
A. Current PMH Priority Risk 
Factors 
B. Priority Risk Factors in Final 
Models 
C. Non-Priority Risk Factors 
in Final Models 
D. Priority Risk Factors not in Final 
Models 
Current or Recent Smoking Current Smoking Recent Smoking 
Current or Recent Substance Use Current or Recent Substance Use 
Unsafe or Unstable housing, IPV, 
Sexual Abuse Unsafe or Unstable Housing (White) IPV, Sexual Abuse 
All Chronic Diseases 
Diabetes, Hypertension, Asthma, Renal, 
Other (White) HIV, Lupus, Seizure, Mental illness 
Fetal Complications  Fetal Complications 
Multiple Gestation Multiple Gestation 
Previous Preterm Birth or Low Birth 
Weight 
Previous Preterm Birth or Low Birth 
Weight 
Delayed or Missed Prenatal Care Delayed Prenatal Care 
Hospitalization or Emergency 
Department Use 
Provider Requests Care Management Provider Requests Care Management 
Non-Hispanic Black  
Nulliparity 
Underweight 
Cervical Insufficiency 
Fetal Death/Second Trimester 
Loss 
Food Insecurity (Parous) 
Obesity (Nulliparous) 
    
Short Interpregnancy Interval 
(Black)   
Italics denotes factors from the Pregnancy Medical Home (PMH) risk screen that were not evaluated. Parentheses denotes the subgroup for which this risk 
factor was a significant predictor of preterm birth. 
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Figure 2.2. Receiver Operating Characteristic (ROC) curve for the final predictive 
model of preterm birth among women screened by the Pregnancy Medical Home 
program (n=15,428). 
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Table 2.12.  
 
Test Characteristics of Models Predicting Preterm Birth among Women Screened by 
the Pregnancy Medical Home Program (n=15,428) 
 
Final  Final  Interaction Priority 
Model  Model  Model Risk Factor 
Test Characteristic 0.11  0.085  0.11 Model 
Area Under Curve 0.66 0.66 0.67 0.64 
Sensitivity 0.44 0.72 0.50 0.79 
Specificity 0.81 0.48 0.74 0.31 
Positive Predictive Value 0.22 0.15 0.19 0.12 
Negative Predictive Value 0.92 0.93 0.92 0.92 
False Negative Rate  0.56 0.29 0.50 0.21 
Correctly Classified 0.76 0.51 0.71 0.36 
Prevalence of a Positive 
Test 0.22 0.54 0.23 0.70 
 
 
 Figure 2.3. Sensitivity analyses comparing odds ratios and 95% confidence intervals from model selection in the full 
sample and among women not receiving care management. 
 
 
Black is non-Hispanic black race. Smoke refers to women who continued to smoke after they found out they were pregnant. Underwt is 
underweight. Diabetes and Hyperten are chronic diabetes and hypertension. Renal is renal disease. Other is “other” chronic conditions. 
Multiple is multi-fetal gestation. Cervical Insuf is cervical insufficiency in the current or a previous pregnancy. Nullip is nulliparous. Non-spon 
PTB and Spon PTB is non-spontaneous and spontaneous preterm birth. LBW is low birthweight. 2nd Tri Loss/FD refers to second trimester 
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 Figure 2.4. Sensitivity analyses comparing odds ratios and 95% confidence intervals from model selection in the full 
sample and among women not receiving 17p. 
 
 
Black is non-Hispanic black race. Smoke refers to women who continued to smoke after they found out they were pregnant. Unintend and DK 
Intent refer to unintended pregnancy and don’t know pregnancy intention. Underwt is underweight. Diab and Hyperten are chronic diabetes 
and hypertension. Renal is renal disease. Other is “other” chronic conditions. Multiple is multi-fetal gestation. Preg Hyperten refers to 
hypertensive disorders of current pregnancy. Cervical Insuf is cervical insufficiency in the current or a previous pregnancy. Nullip is 
nulliparous. Non-spon PTB and Spon PTB is non-spontaneous and spontaneous preterm birth. LBW is low birthweight. 2nd Tri Loss/FD refers 
to second trimester loss or fetal death.   
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 Figure 2.5. Sensitivity analyses comparing odds ratios and 95% confidence intervals from model selection with 
different outcome definitions (less than 37, 34, and 32 weeks gestation). 
 
 
Black is non-Hispanic black race. Smoke refers to women who continued to smoke after they found out they were pregnant. Underwt is 
underweight. Diabetes and Hyperten are chronic diabetes and hypertension. Renal is renal disease. Other is “other” chronic conditions. 
Multiple is multi-fetal gestation. Cervical Insuf is cervical insufficiency in the current or a previous pregnancy. Nullip is nulliparous. Non-spon 
PTB and Spon PTB is non-spontaneous and spontaneous preterm birth. LBW is low birthweight. 2nd Tri Loss/FD refers to second trimester 
loss or fetal death.  
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CHAPTER 3. RECEIPT OF POSTPARTUM CONTRACEPTION AMONG WOMEN 
WITH AND WITHOUT A RECENT PRETERM BIRTH 
INTRODUCTION 
Preterm birth (PTB) prior to 37 weeks completed gestation is the most 
frequent cause of infant death and the leading cause of long-term neurological 
disabilities in the United States.3 The strongest and most consistent predictor of 
preterm birth is a history of PTB.33–36 A previous PTB can double the risk of a future 
PTB.8 For reductions in PTB to be realized, interconception care strategies are 
especially needed for these high-risk women. Black women have been shown to 
have a higher recurrence of preterm delivery as compared to white women.37 Thus 
interventions in the interconception period also have the potential to reduce 
disparities in PTB.31 
Two interconception care strategies that have the potential to reduce 
recurrent PTB risk are optimizing interpregnancy intervals and avoiding unintended 
pregnancies.39,81 A short interval between pregnancies is associated with an 
increased risk of PTB.40–47 Infants conceived less than six months following a live 
birth had an odds ratio of 1.4 (95% CI 1.3–1.5) for PTB as compared to those 
conceived 18 to 23 months after a live birth.46 Short interpregnancy intervals (IPIs) 
are also associated with an increased risk of recurrent PTB among women who 
experienced a previous PTB.48 Nationally representative estimates from the 2006–
2010 National Survey of Family Growth indicated that 35% of second or higher-order 
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births within five years of the survey interview had interpregnancy intervals of less 
than 18 months.82 Women whose pregnancies are unintended are also more likely to 
deliver preterm.50,51 It is not clear whether this is a causal association or whether the 
finding reflects residual confounding based on differences in sociodemographics and 
health behaviors of women who have unintended versus intended pregnancies.50 In 
the United States, nearly half of all pregnancies are unintended.49 
To successfully space births and avoid unintended pregnancies, women need 
access to highly effective methods of contraception.81 Analysis of postpartum 
contraceptive provision in publicly funded programs in California documented that 
women who received postpartum contraception 90 days after delivery were 0.66 
(95% CI: 0.63, 0.69) times as likely to have a short IPI (less than 18 months) for their 
subsequent pregnancy than women not receiving contraception.83 Furthermore, 
women who received long-acting reversible contraception (LARC) had 3.89 (95% CI: 
3.55, 4.26) times the odds and women who received user-dependent hormonal 
contraception had 1.89 (95% CI: 1.90, 1.98) times the odds of an optimal pregnancy 
interval compared to women receiving barrier methods only.84 These studies provide 
evidence that postpartum contraception obtained early in the postpartum period, 
particularly highly effective methods, can help women achieve optimal pregnancy 
intervals. A systematic review conducted by Hogue and colleagues (2011) estimated 
that 4% of preterm births among whites and 8% among African Americans could be 
averted by increasing IPIs to 18–23 months.66  
Finally, women who use contraception consistently and correctly are much 
less likely to have unintended pregnancies. According to national data reported by 
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the Guttmacher Institute, the two-thirds of women who use contraceptives 
consistently and correctly account for only 5% of all unintended pregnancies in a 
given year. This is in contrast to the 16% of women who do not use any 
contraceptives and who account for half of all unintended pregnancies.85 
Data on whether postpartum contraceptive practices differ between women 
with and without a previous preterm birth are lacking.38 A study of 300 postpartum 
women from a randomized control trial conducted in NC in 2011–2012 assessed 
women’s intentions to use LARC. A slightly lower percentage of women delivering 
preterm intended to use LARC (36.7% versus 38% of women delivering at term), but 
these differences were not statistically significant.86 
In the Philadelphia Collaborative Preterm Prevention Project, Bloch et al. 
(2012) followed women with a recent delivery before 35 weeks of gestation and at 6 
months postpartum assessed pregnancy intention and contraceptive method 
effectiveness. Over half of the sample wanted to delay a pregnancy but reported 
using low or moderately effective methods, such as withdrawal, or no method at 
all.38 The reasons why women who wanted to delay pregnancy but did not use more 
effective methods of contraception were largely unexplained. Low educational 
attainment was the only variable that significantly predicted the use of a less-
effective contraceptive method among women wanting to delay pregnancy.38 The 
authors concluded that less-effective method use among women with lower 
education was perhaps due to a lack of knowledge and less access to health 
services.38 
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The primary purpose of this analysis was to compare receipt of contraception 
in the postpartum period for women who experienced a preterm birth with 
contraception receipt among women who had a term birth. There is some evidence 
from qualitative data that women consumed with caring for a premature infant, 
particularly infants with an earlier gestational age who have an increased likelihood 
of health problems, have less time for self-care.68 Therefore we hypothesized that 
women with a PTB would have a lower likelihood of contraceptive receipt compared 
to women who delivered full term.  
Furthermore, the experience of caring for a very preterm infant (less than 32 
weeks completed gestation), whose risk for adverse neonatal outcomes and 
developmental impairments are greatest,87–89 may make it even more difficult for 
women to obtain family planning services within 90 days following delivery. Thus we 
hypothesized that the association would be even stronger for women with very 
preterm births as compared to women who delivered moderately preterm (32 to less 
than 37 weeks completed gestation) or full term.  
We also hypothesized that this association might vary for women with 
different parity. Qualitative data from the Philadelphia Collaborative Preterm 
Prevention Project has also documented that low-income women with children may 
forgo their own health care to prioritize their children’s needs when faced with 
multiple burdens.68 Thus we expected the likelihood of contraceptive receipt among 
women with a recent PTB to be even lower among women with higher parity. We 
explored these hypotheses while controlling for key sociodemographic, reproductive, 
chronic health, and healthcare access characteristics.  
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Our second aim was to describe method effectiveness in this sample and 
compare between women who delivered preterm and full term. Because we 
hypothesized that women who delivered preterm would have a lower likelihood of 
receiving contraception, we expected that they would also be less likely to receive 
moderately or highly effective methods of contraception than women who delivered 
at term.  
To answer these research questions we used data from North Carolina, 
where the preterm birth rate has been historically higher than the U.S. average. 
Approximately 12% of births were preterm in 2012 compared to 11.6% for the 
national average,4,90 and, according to the Pregnancy Risk Assessment and 
Monitoring System (PRAMS) in 2011 in NC, 13.8% of mothers reported a previous 
PTB.91 Among women who gave birth in 2011 in NC and had a previous delivery, 
41.6% had less than 18 months between the date of conception and the date of the 
previous delivery.92 Also in 2011, 42.7% of pregnancies ending in a live birth were 
unintended; this rate was 56% for Medicaid recipients.93 These data suggest that 
strategies addressing short IPIs and unintended pregnancy could impact PTB rates 
among publicly insured women in NC. 
In response to high rates of PTB in North Carolina, Community Care of North 
Carolina (CCNC) launched the Pregnancy Medical Home program in partnership 
with the North Carolina Division of Medical Assistance (DMA) in 2011. CCNC, a not-
for-profit organization, manages the care of Medicaid recipients statewide. The PMH 
program seeks to provide evidence-based, high-quality maternity care to improve 
birth outcomes in the pregnant Medicaid population,54 which comprises 47% of all 
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pregnancies.53 Medicaid provides emergency coverage of the delivery only for 
another 8% of births.53 Patients at risk of poor birth outcomes are identified through 
a standardized risk screening administered at the first prenatal visit and are referred 
for pregnancy care management to address their risk factors. Pregnancy care 
management services continue through the postpartum period, which is defined by 
Medicaid as ending on the last day of the month in which the sixtieth postpartum day 
occurs. During the postpartum period, PMH practices receive an incentive payment 
for performing a postpartum visit, which must address the patient’s reproductive life 
plan and involve arranging ongoing care beyond the maternity period such as 
referral to the Family Planning Waiver. Given that 65% of our cohort qualified for 
Medicaid through the Medicaid for Pregnant Women (MPW) category and thus may 
lose coverage within 90 days of delivery, we were particularly interested in whether 
women received contraception during this time period and, if they did receive it, how 
effective were the methods they received.  
METHODS 
Data Source 
We conducted a retrospective cohort analysis using data from three sources: 
birth certificates, Medicaid delivery and contraceptive claims, and the risk screening 
form from CCNC’s Case Management Information System (CMIS). Birth certificate 
data are matched to Medicaid delivery claims in the Division of Medical Assistance 
(DMA) data warehouse using SQL Server Integration Services Fuzzy Lookup 
component software, producing a match rate of 95%. The risk screening is 
administered at the first prenatal visit at a median of 17 weeks gestation and is 
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entered into CMIS. The provider collects a medical history and checks a box for the 
presence of a risk factor; psychosocial questions like pregnancy intention are self-
administered in English, Spanish, or Russian, or may be completed through a 
patient interview. The risk screening was linked to the index birth via the mother’s 
Medicaid ID. 
All women with a corresponding delivery ending in a live birth between 
September 1, 2011, and September 30, 2012, with a valid risk screening by the 
PMH program were eligible for analysis (n=34,845). To examine contraception 
received within 90 days of delivery, Medicaid claims for contraceptive methods were 
linked with dates of service through December 31, 2012. Women were excluded if 
they had only Emergency Medicaid (n=13), had a live birth prior to 24 weeks 
gestation (n=108), or had a hysterectomy within 90 days of delivery as indicated by 
Medicaid claims or on the birth certificate (n=25). We excluded 2,052 (5.9%) women 
missing observations on the following covariates of interest: marital status, 
breastfeeding at discharge, pre-pregnancy body mass index (BMI), parity, and 
pregnancy intention. The final sample size was 32,647 women (Figure 3.1). 
All study procedures were reviewed and approved by the Institutional Review 
Board for the Protection of Human Subjects at the University of North Carolina at 
Chapel Hill.  
Measures  
The primary outcome was receipt of any contraception (yes or no) during the 
90-day postpartum period. Family planning services covered under Medicaid include 
consultation, examination, and treatment prescribed by a physician or under a 
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doctor’s supervision, lab exams and tests, and medically approved methods, 
supplies, and devices to prevent conception including Depo-Provera and Lunelle 
injectables, ParaGard and Mirena IUCs, oral contraceptives, Implanon/Nexplanon 
implantable devices, diaphragm fitting, sterilization (tubal ligation and the Essure 
procedure) and Ortho Evra patch.94 
Any women with at least one outpatient pharmacy claim, physician drug 
program claim, or physician claim for insertion of a long-acting method or for 
performing a sterilization procedure for the following contraceptive methods or 
procedures during the 90 day postpartum period were classified as having received 
a method of contraception: tubal ligation or Essure procedure, implant, intrauterine 
device, injectable, patch, ring, oral contraceptives, or diaphragm fitting. We also 
classified women as receiving long-acting reversible contraception (LARC) if they 
received any intrauterine contraception (implant or intrauterine device). Women 
could be classified as receiving more than one method type, thus the types of 
methods are not mutually exclusive. Emergency contraception was not included 
because we were interested in primary prevention measures.  
As a second outcome, we examined contraceptive method effectiveness tiers 
(most, moderate, and least [referent]) based on contraceptive failure rates in the 
United States.95,96 The most effective tier included women who received a 
sterilization procedure or who had an implant or intrauterine contraception (IUC) 
placed. The moderately effective tier included injectable, patch, ring, oral 
contraceptives, or diaphragm. The least effective tier included women who had no 
contraceptive claim during the 90-day postpartum period. For the effectiveness tier 
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outcome, women who received multiple types of contraception were classified by the 
most effective method received so tiers are mutually exclusive. Likewise, 81 women 
(0.25%) who had an implant or IUC removal were classified in the most effective tier 
even if they had a claim for a less effective method or no claim at all after the 
removal claim date.  
Our measures of contraceptive receipt and effectiveness do not capture 
methods not billed by Medicaid such as withdrawal, condoms, vasectomy, natural 
family planning or rhythm method, lactational amenorrhea, or abstinence. Women 
using these methods were classified as not receiving any contraception and as the 
least effective method tier. 
The main exposure of interest was preterm birth (less than 37 weeks 
completed gestation) defined using the obstetric estimate of gestation from the birth 
certificate. Additionally, we examined a narrower definition of preterm birth (less than 
32 weeks) for sub-analyses. We tested for interaction by parity. Parity was 
calculated from the birth certificate by adding the number of live births now living and 
now dead and dichotomized as two births or less vs. more than two births [referent]. 
We added one to the measure to include the most recent birth. 
The remaining variables from our conceptual model (Figure 3.2) were 
evaluated as potential confounders. Reproductive health characteristics from the risk 
screen included a short interpregnancy interval (IPI), defined as less than 12 months 
between the last live birth and conception of the current pregnancy, a previous PTB, 
and a previous low birth weight (LBW) infant. Pregnancy intention, also assessed on 
the risk screening, was collapsed into four categories: intended (wanted to be 
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pregnant sooner/now) [referent], wanted to be pregnant later (mistimed), did not 
want to be pregnant then or any time in future (unwanted), or don’t know. We used a 
proxy for breastfeeding, whether the infant was being breastfed at discharge 
(yes/no), as reported on the birth certificate.  
We controlled for chronic health conditions (pre-pregnancy BMI, diabetes, 
and hypertension) because there is some evidence that contraceptive receipt may 
vary by chronic disease status and chronic conditions could function as competing 
medical priorities to women’s family planning needs.97 BMI was calculated using the 
participant’s weight and height from the risk screening and categorized into four 
groups: underweight (<18.5), normal (18.5–24.9) [referent], overweight (25.0–29.9), 
or obese (>30). About 18% were missing BMI; these data were substituted with a 
categorical BMI measure calculated from birth certificates (kappa for non-missing 4-
category BMI 0.78). Chronic diabetes and hypertension from the risk screening were 
dichotomous.  
We included several covariates to control for healthcare access including 
Medicaid program status, delayed prenatal care, language spoken, and rurality. 
Medicaid program category from claims data was collapsed into MPW versus any 
other category of Medicaid. Most women in our sample qualify for Medicaid because 
of pregnancy and thus do not have coverage prior to pregnancy or beyond 90 days 
after delivery, while women qualifying under other categories have continuous 
coverage. Delayed prenatal care from the risk screening was defined as initiation 
after 14 weeks gestation. Non-English speaking was also assessed on the risk 
screening. County of delivery from the birth certificate was used to categorize 
70 
women into three groups: metropolitan, micropolitan (urban areas based around an 
urban cluster), and rural according to North Carolina’s core-based statistical area as 
defined by the U.S. Office of Management and Budget.98 
Sociodemographic characteristics from birth certificates included age, 
race/ethnicity, nativity, marital status, and education level. Age at delivery was 
calculated by subtracting the mother’s date of birth from the delivery date and 
categorized as <18, 19–34 [referent], and >35. Race/ethnicity was categorized as 
non-Hispanic white [referent], non-Hispanic black, Asian/Pacific Islander (API), 
American Indian/Alaska Native, Hispanic, and Other. Marital and U.S.-born status 
were dichotomous. Educational attainment was collapsed into four groups: less than 
high school [referent], high school graduate or GED, some college or Associate’s 
degree, or college graduate or more.  
Analysis 
Descriptive statistics and bivariate analyses (including Pearson’s chi-square 
tests) were used to compare the distributions of sociodemographic, health, and 
access characteristics by our main exposure, PTB (Table 3.1), and outcome, receipt 
of contraception (Table 3.2). We then examined the distribution of contraception 
receipt, method type, and effectiveness tier by PTB (Table 3.3). To address the 
primary and secondary aim of the analysis, we calculated the crude and adjusted 
association between PTB and contraceptive receipt using logistic regression (Table 
3.4) and between PTB and contraceptive effectiveness using multinomial logistic 
regression (Table 3.5). To examine the impact of very preterm birth on contraceptive 
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receipt, we repeated all analyses using less than 32 weeks gestation as our key 
exposure (Tables 3.6–3.9). 
We tested for interaction by parity using an a priori alpha level of significance 
of 0.05. We assessed for confounding by all other covariates from our conceptual 
model by checking whether covariates appeared to have a strong effect with the 
exposure, the outcome in the unexposed, or both, and by calculating the change in 
the odds ratio between the crude and adjusted. We kept covariates in the final 
models, even if they were not significantly associated with contraceptive receipt or 
effectiveness, if they showed evidence of confounding in bivariate analyses and did 
not largely impair the precision of estimates in the final models.  
To examine the robustness of our findings to exclusions on missing data, we 
compared crude estimates from the complete case analysis to crude estimates from 
all available data including women who had been excluded due to missing data on 
key covariates. All analyses were conducted using Stata version 13.0 (StataCorp. 
2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.) 
RESULTS 
The cohort included 32,647 women who had a live birth between September 
2011 and September 2012. Median age was 24 years. One-third of the sample was 
married and one-fourth had not completed high school. Seventy percent of women 
had two or fewer births (including the most recent birth), and 55% reported that their 
most recent birth was unintended (44% mistimed and 11% unwanted). Nearly 6% 
had an interpregnancy interval less than 12 months. Not counting the most recent 
delivery, a previous PTB was reported by 7.5% of women and 1.9% of women had a 
72 
previous LBW baby. Over half were overweight or obese. The majority of women 
(65%) were covered under MPW and resided in metropolitan areas. About a quarter 
of all women entered prenatal care late, after 14 weeks of gestation. 
The prevalence of preterm birth was 10.1% (95% CI: 9.80, 10.46) (Table 3.1). 
PTB was more common among women 35 years or older, those born in the United 
States, and those who were unmarried. Black women and women from “other” 
race/ethnicities had a higher rate of PTB. A short IPI and pregnancies reported as 
unwanted or “don’t know” were more likely to be preterm. Higher parity, a previous 
PTB and LBW infant were strong risk factors for PTB. The prevalence of PTB was 
lower among women who reported breastfeeding at discharge and was higher 
among women who were underweight or had diabetes or hypertension. Women with 
MPW status had a lower prevalence of PTB, as did non-English speakers and 
women residing in micropolitan or rural areas.  
The prevalence of any contraceptive claim within 90 days of delivery was 
52% (Table 3.2). Contraception receipt was more common among women 18 or 
younger, white or American Indian/Alaska Native women, and those born in the 
United States. High school graduates and women who had some college education 
had a higher prevalence of contraceptive receipt. Women with more than two births 
had a reduced prevalence of contraceptive receipt compared to women with two 
births or fewer (49.3%, 95% CI: 48.28, 50.32 vs. 52.9%, 95% CI: 52.29, 53.57). 
Women with a previous PTB or LBW baby had a lower prevalence of contraceptive 
receipt. Contraception receipt was higher among women breastfeeding at discharge 
and women who did not have a short IPI. Women whose last birth was mistimed had 
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the highest prevalence of contraception receipt among all pregnancy intentions 
examined. Of note, nearly 11%, or 3,550 women, reported early in pregnancy of the 
index birth that they did not want to be pregnant then or any time in the future, yet 
only half had a contraceptive claim postpartum. Obese women were more likely to 
have received contraception. MPW status was associated with an increased 
prevalence of contraceptive receipt. Women who entered prenatal care in the first 
trimester, English speakers, and residents of micropolitan or rural areas were also 
more likely to have received contraception.  
Among the entire sample, oral contraceptives were the most common form of 
contraception received (15.3%), followed by IUCs (13.8%), injectables (9.2%), and 
sterilization (8.5%) (Table 3.3). Less than one-third of mothers received the most 
effective methods of contraception and only one-fourth received a moderately 
effective method.  
Women with a recent preterm birth had a slightly lower prevalence of any 
contraception receipt within 90 days postpartum (50%, 95% CI: 48.25, 51.66 vs. 
52%, 95% CI: 51.55, 52.69) (Table 3.3). Specifically, women who delivered preterm 
were less likely to have a claim for an IUC and more likely to receive injectables. 
Due to these differences in method type, women who delivered preterm were 
classified as less likely to receive the most effective methods but not moderately 
effective methods. The prevalence of any contraceptive receipt among women with 
more than two births who had a PTB was 44% (95% CI: 41.53, 47.40) compared to 
50% (95% CI: 48.87, 51.04) of their counterparts with a term birth. Among women 
with two or fewer births, 53% received any contraception regardless of PTB status. 
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To answer our primary research question, we examined the log odds of any 
contraceptive receipt by preterm birth. Women who delivered preterm had 8% lower 
odds of receiving any contraception, OR = 0.92 (95% CI: 0.85, 0.99) (Table 3.4). The 
association between PTB and any contraceptive receipt differed by parity, such that 
women with a PTB and more than two births were significantly less likely to receive 
any contraception, OR = 0.84 (95% CI: 0.74, 0.96), than women with more than two 
births who had a term birth. There was no difference between gestational age at 
delivery and any contraceptive receipt among women with two births or fewer, OR = 
1.01 (95% CI: 0.92, 1.10).  
Women who had a PTB were less likely to receive the most effective methods 
of contraception, OR = 0.87 (95% CI: 0.80, 0.95), in the crude multinomial logit 
model (Table 3.5). This association remained statistically significant in the adjusted 
model, aOR = 0.89 (95% CI: 0.81, 0.97). Women with and without a preterm birth did 
not appear to differ in their receipt of moderately-effective contraception. 
Because we hypothesized that women with very early PTB (<32 weeks) 
would be even less likely to receive any contraception due to the increased strain of 
caring for a premature infant, we conducted sub-analyses with very preterm birth 
(n=582, 1.8%) as our key exposure measure (Table 3.6). Fewer women with a very 
PTB received any contraception (46.6%) compared to women delivering at or after 
32 weeks (52.0%) (Table 3.7). The crude odds ratio was even more reduced than for 
women delivering at less than 37 weeks (0.80, 95% CI: 0.68, 0.95). The adjusted 
estimates for any contraceptive receipt for a very PTB were decreased for both 
parity groups (Table 3.8). The adjusted OR for very PTB among women with more 
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than two births was 0.64 (95% CI: 0.46, 0.90) compared to their counterparts who 
delivered at or after 32 weeks of gestation. Among women with two births or fewer, 
the odds ratio for any contraceptive receipt associated with a very preterm delivery 
was 0.89 (95% CI: 0.73, 1.08). The adjusted association between very PTB and the 
most effective tier was 0.57 (95% CI: 0.45, 0.71) compared to women delivering at 
or after 32 weeks of gestation (Table 3.9).  
There were a number of other factors from our conceptual model that were 
associated with any contraceptive receipt and the effectiveness tier. All 
sociodemographic factors except for marital status were significantly associated with 
any contraceptive receipt and effectiveness tier. Adjusting for other covariates, 
young age increased the odds of receiving both a moderate and the most effective 
method (Table 3.5). All minority groups had a lower odds of obtaining the most 
effective methods compared to whites; however, this difference was statistically 
significant only for black, API, and Hispanic women. U.S.-born women had higher 
odds of moderately-effective method receipt. Women who graduated from high 
school or had some college education were more likely than women who did not 
finish high school to receive moderate and the most effective methods.  
Similarly, there were a number of reproductive health factors associated with 
any contraceptive receipt and effectiveness. Focusing on contraceptive 
effectiveness, women with more than two births were more likely to be categorized 
as receiving the most effective method types and less likely as receiving moderately 
effective methods due to a much higher rate of sterilization in this group. Compared 
to women whose last live birth was intended, all other groups had a higher likelihood 
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of receiving the most effective methods. The odds of receiving the most effective 
method were 1.34 times (95% CI: 1.25, 1.44) and 1.48 times (95% CI: 1.35, 1.63) 
the odds of receiving the most effective method for women with mistimed and 
unwanted births, respectively, compared to women with intended births. Mothers 
with short IPIs were less likely to receive moderately effective methods but more 
likely to receive the most effective methods.  
Only one chronic health condition affected any contraceptive receipt and 
effectiveness tier. Specifically, underweight women were less likely and overweight 
and obese women were more likely to receive the most effective methods, but there 
were no differences in receipt of moderately effective methods. This effect was 
largely driven by a higher percentage of sterilization claims for obese women than 
non-obese women (11.7% vs. 6.9%).  
Finally, all but one of the healthcare access factors were associated with any 
contraceptive receipt and effectiveness tier in the fully adjusted models. MPW status 
and residing in a micropolitan area were associated with higher likelihoods of 
receiving the most effective methods. Delayed prenatal care was negatively 
associated with receipt of both moderate and the most effective methods.  
Our sensitivity analysis fitting crude models using all available data including 
women with missing data on covariates of interest (n=2,052, 6%), rather than the 
complete case sample, indicates that interpretation of our findings does not change 
based on these exclusions. Excluded women were more likely to be older in age, 
Asian or Pacific Islander, foreign-born, have lower education, and reside in rural 
areas. They were less likely to be American Indian, have delayed prenatal care, or 
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reside in a micropolitan area. The crude OR for preterm birth and any contraceptive 
receipt including women with missing data of 0.91 (95% CI: 0.85, 0.97) was very 
close to our crude estimate of 0.92 (95% CI: 0.85, 0.99) in our complete case 
analysis sample. 
DISCUSSION 
Our analysis documents that in NC, a state with a higher than average 
preterm birth rate, any contraceptive receipt from Medicaid in the early postpartum 
period for women with a recent preterm birth was low. Fifty-two percent of all women 
received some form of contraception, but only 28% (95% CI: 27.11, 28.08) received 
the most effective methods. Among women who were at highest risk of recurrent 
PTB as a result of having recently had a PTB, the prevalence of contraceptive 
receipt was slightly lower (50%), and only 25% received the most effective methods. 
Finally, the prevalence of contraceptive receipt was just 44% for women who had 
more than two births and whose most recent birth was preterm, compared to 50% 
among their counterparts with term births. Our findings support the call for improved 
family planning services to be an integral part of preterm birth prevention efforts for 
reductions in PTB to be realized.81  
We found support for our main hypothesis that PTB was associated with a 
decreased likelihood of any contraception receipt. Once we adjusted for 
sociodemographic, reproductive, and chronic health variables and healthcare access 
characteristics, this association remained statistically significant among women with 
more than two births only. Higher parity women had a 15% reduced odds of 
receiving any contraception if they had a recent PTB compared to equal parity 
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women with a full term birth. However, delivering preterm did not have as much of 
an impact on any contraceptive receipt among lower parity women.  
Though our data do not provide direct information to test why women with a 
recent PTB and more than two births were less likely to be dispensed contraception, 
we speculate that these findings reflect the difficulty low-income women encounter 
early postpartum to obtain family planning services when trying to meet the 
demands of caring for a preterm infant in addition to other children. Lu and 
colleagues (2006) note that women who have a PTB may require multiple services 
in the interconception period, particularly if their children have disabilities and special 
healthcare needs, and that fragmentation of service delivery can deter access to 
care particularly for low-income women with multiple burdens.32 In a longitudinal 
ethnographic study among African American women of preterm infants who 
participated in an interconceptional PTB risk reduction intervention in Philadelphia, 
Hogan et al. (2013) observed that having multiple children compounds the demand 
for women with a recent preterm delivery who spend much of their time attending 
health or social service visits for their children.68 Women would forgo their own 
health care to make sure their children’s needs were met first.68 Even when 
traditional barriers were removed in this trial by providing transportation, child care, 
and flexible clinic hours, fewer women than expected attended interconception care 
visits.99  
Further support for our hypothesis was found when we narrowed the 
gestational age window of our exposure to 32 weeks. Women with more than two 
births and a very preterm infant had 36% lower odds of receiving contraception than 
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women who delivered at or after 32 weeks gestation with more than two births. 
Among women with two births or fewer, the odds of contraceptive receipt was 
reduced (aOR = 0.89, 95% CI: 0.73, 1.08) compared to women with two births or 
fewer delivering at 32 weeks or later, but was not statistically significant. Perhaps the 
trauma and stress associated with the experience of a preterm delivery,100–102 or the 
experience of caring for a very preterm infant whose risk for adverse neonatal 
outcomes and developmental impairments are greatest87–89 may make it even more 
difficult for women to prioritize family planning services within 90 days following 
delivery. The Postpartum Plus Prevention Program conducted in one NC hospital 
among mothers of medically fragile infants in the NICU found that provision of 
contraception needed to be immediately available, but engaging in true reproductive 
life planning was difficult before six months because mothers were consumed with 
meeting the more urgent needs of their infants.103 
Another potential explanation is that family planning is less of a priority for 
their providers, who are busy addressing other health needs for these women and 
infants given their more complicated postnatal circumstances. For women attending 
multiple appointments for the care of a preterm infant, clinic protocols that 
continually provide contraceptive counseling and method provision may facilitate the 
uptake of contraception.83,104 
We also found that women with a recent preterm delivery were less likely to 
receive the most effective methods of contraception, controlling for potential 
confounders, OR = 0.89 (95% CI: 0.81, 0.97). This was largely driven by the fact that 
women with a recent preterm delivery were less likely to receive an IUC. Evaluation 
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data from an interconceptional program for women with a previous adverse 
pregnancy outcome in Chicago may provide some insight into the low rates of highly 
effective contraception in our sample.105 In this intervention that helped women to 
set reproductive goals and ensured access to contraception, many women reported 
using less effective contraception despite not wanting to get pregnant within six 
months.105 Their perceptions about the effectiveness of methods were inconsistent 
with clinical effectiveness. For example, almost one-quarter of women considered 
withdrawal and the calendar method to be somewhat to very effective, while half 
reported the IUC to be somewhat or very effective.105–106 Moreover, meeting the 
objectives of the interconception care program was hindered because of more 
pressing socioeconomic issues perceived by program participants such as housing 
and employment. To increase uptake of the most effective methods, more education 
on the effectiveness of contraceptive methods is needed105 and perhaps better ways 
of presenting this information.106 Furthermore, women need additional support to 
meet the more pressing socioeconomic demands so that they can then prioritize 
interconception health and contraception.  
Our analysis provides baseline data from which the PMH program can work 
to increase postpartum contraceptive receipt and effectiveness to reduce PTB and 
resulting mortality and morbidity among women with Medicaid and their infants in 
NC. Care coordination provided by the PMH program will be essential for these 
women.32 Other than the first postpartum visit, women on Medicaid during 
pregnancy may have limited access to health care between pregnancies.32 Despite 
research on the importance of the postpartum visit for contraceptive uptake,83,107 
81 
national performance measures from Healthcare Effectiveness Data and Information 
Set (HEDIS) indicate that only 64.4% of Medicaid deliveries had a postpartum visit 
on or between 21 and 56 days after delivery in 2010.108  
Care managers can play a vital role in helping women schedule and attend 
their postpartum visit and by working with providers to ensure that contraceptive 
counseling and method dispensing is offered to women throughout the postpartum 
period. Given the high risk of these women for recurrent PTB, contraceptive 
counseling should include information on the medical risks of short pregnancy 
intervals.83 Another key activity for care managers will be to connect women who are 
losing Medicaid coverage to the Family Planning Waiver. According to data from NC 
PRAMS in 2011, less than half of Medicaid recipients surveyed had heard of the 
Medicaid Family Planning Waiver or Be Smart Program.109  
Finally, evaluation data from interconception interventions mentioned 
previously suggest that these efforts will not be successful in helping them achieve 
their reproductive plans without paying attention to the context of women’s lives 
more holistically and the multiple burdens they encounter.32,68,69,72,99,105,110–112 To 
support women more holistically, 90 days of Medicaid coverage and care 
management services in the postpartum period is insufficient. Efforts to support 
ongoing medical coverage among women with adverse birth outcomes, such as 
through an Interconception Care Waiver or access to exchange plans, would 
potentially enable more women to achieve optimal pregnancy spacing.113 
The association between preterm birth and any contraceptive receipt among 
parous groups remained significant when we controlled for confounders traditionally 
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included in studies examining postpartum contraception such as age, race/ethnicity, 
nativity, and education level,38,84 as well as for measures of healthcare access. As 
has been found in other studies, any contraception receipt was highest among 
mothers 18 or younger and decreased with increasing age38,84 and with increasing 
parity.38,114 Contraceptive receipt ranged from a low of 42% among Asian and Pacific 
Islander women to 55% among non-Hispanic whites. Postpartum contraceptive 
receipt was also lowest among Asian and Pacific Islander women in a study 
analyzing Medicaid claims in CA and PRAMS data from 12 states.83,115 Foreign-born 
women in our study were less likely to receive contraception. Contraceptive receipt 
generally increased with education level but bottomed out for women who were 
college graduates or higher, as is the trend among nationally representative 
contraceptive use data from the National Survey of Family Growth (NSFG).114 
Linkage of risk factor data from the Pregnancy Medical Home program with 
birth certificates and Medicaid claims enabled us to examine and control for a 
number of novel factors including chronic conditions and healthcare access. Pre-
pregnancy BMI was the only chronic condition that remained predictive in final 
models. Underweight women were less likely to receive any contraception, and the 
most effective methods in particular, while overweight and obese women were more 
likely to receive any contraception and more effective methods (mostly sterilization). 
Receipt of postpartum contraception did not differ by the presence of diabetes or 
hypertension.  
The literature on chronic conditions and postpartum contraception is limited 
and findings are mixed.116–118 We speculate that the increased likelihood for the 
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most effective methods, but not moderately effective methods, among overweight 
and obese women may reflect patient or provider perceptions that sterilization may 
be more appropriate given the increased health risks and possible increased failure 
rates of hormonal methods among these women.119,120 Given the increased risk of 
pregnancy complications among women with chronic conditions, including PTB, 
further research is warranted to clarify how individual conditions influence 
contraceptive use. 
We examined several barriers to healthcare access. In our analysis, women 
with MPW status were 1.11 times as likely to receive contraception and more likely 
to receive both moderate and most effective methods than women who qualified for 
Medicaid under other categories. This finding is contrary to reports from PRAMS in 
12 states that showed the most effective method use was more common among 
women with pre-pregnancy Medicaid coverage compared to those without coverage 
prior to pregnancy.115 It is possible that women with MPW coverage were more 
motivated to obtain contraceptive methods, particularly those that do not require 
regular contact with the healthcare system, because their Medicaid coverage ends 
90 days after delivery while non-MPW women who maintain coverage longer do not 
feel the same urgency.121 One limitation of this research is that we do not capture 
contraceptive receipt among women who start a method after 90 days postpartum, 
which may explain the discrepant findings with PRAMS data.  
With regard to other access characteristics, women who entered prenatal 
care late, who did not speak English, and who lived in metropolitan areas were less 
likely to receive any contraception. We did not assess why women entered prenatal 
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care late and thus we cannot determine whether individual selection factors or 
structural barriers on the health delivery side explain why women with delayed 
prenatal care were less likely to receive both moderate and the most effective 
methods. Delayed prenatal care has been associated with a lower likelihood of 
highly effective methods in PRAMS data as well.115 Though non-English speakers 
were less likely to have received contraception, this finding did not persist in 
multivariate models likely due to the strong association between nativity and spoken 
language.  
Our finding that residing in a rural or micropolitan area was associated with 
higher odds of moderate and the most effective methods was surprising given 
literature that rural residents face more barriers to health care.122,123 However, one 
other study analyzing postpartum contraception use in PRAMS from Michigan in 
2004–2008 also found that women living in rural areas were more likely to use highly 
effective methods compared to their urban counterparts.124 Anecdotal evidence in 
NC suggests that there may be fewer private practices per patient serving Medicaid 
beneficiaries in urban than non-urban areas, causing safety net providers to be 
overburdened, thereby making it difficult for women to obtain care. In our sample, 
delayed prenatal care was more common among urban women (27%) compared to 
18% and 14% in micropolitan and rural areas, respectively. Whether or not this trend 
continues in the postpartum period is unknown, but our data suggest that urban 
women may encounter more barriers, both prenatally and for postpartum 
contraception. An alternate explanation may be that women residing in rural areas 
may request methods that do not require follow-up.  
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Among women who delivered preterm, 54% of pregnancies were unintended, 
yet only 52% of women with unintended pregnancies received contraception 90 days 
after delivery. For comparison, nationally in 2009 according to PRAMS data, 43% of 
women’s most recent pregnancies were unintended and 47% who were not trying to 
get pregnant reported using contraception at the time of conception.125 The low 
prevalence of postpartum contraception in our sample among women at high risk for 
recurrent PTB highlights the need for increased efforts to provide family planning to 
these women. Despite the low prevalence of contraception among women with 
unintended pregnancies, on a positive note, these women were more likely to 
receive the most effective methods compared to women with intended pregnancies.  
We qualitatively compared the prevalence estimates of contraceptive receipt 
in our sample to those of other studies analyzing postpartum contraception with 
Medicaid claims in California and PRAMS in NC. The prevalence of a contraceptive 
claim in our sample (52%) was higher than a recent study, which estimated that 41% 
of 117,644 women in CA served by California’s Medicaid program (Medi-Cal) or its 
family planning expansion program (Family PACT) had a contraceptive claim within 
90 days of delivery.83 Their study excluded women who had a documented 
sterilization at the time of the delivery, which may in part explain the higher 
prevalence in our sample. 
According to NC PRAMS in 2011, 88% of women surveyed 2–9 months 
postpartum reported that they or their partner were doing something to keep from 
getting pregnant.126 The higher prevalence in PRAMS is expected given it includes 
methods not captured by Medicaid claims. The prevalence of methods not captured 
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by Medicaid claims in PRAMS was 2% for vasectomy, 5% for rhythm or natural 
family planning, 30% for condoms, 18% for withdrawal, and 8% for abstinence (note 
these categories are not mutually exclusive and emergency contraception was 
assessed in PRAMS but individual prevalence was not reported).126 The lower 
prevalence observed in our data may also reflect that PRAMS is self-reported data 
and allows more time for a women to obtain contraception (2–9 months postpartum). 
We also compared the prevalence of methods captured in our sample with 
Medicaid recipients from the 2011 NC PRAMS data. Tubal ligation was 13.9% 
among Medicaid recipients in PRAMS versus 8.5% in our sample; oral contraception 
was 21.5% vs. 15%; injectable was 17.1% vs. 9.2%; IUC was 20.9% vs. 13.8%.126 
The remaining methods were reported only for the full PRAMS sample, which 
includes privately insured women. Prevalence of reporting an implant was 2% vs. 
5% in our sample; and the patch, ring, morning-after pill, or diaphragm grouped 
together were 3.7% vs. 2.1% in our sample minus the morning-after pill.126 In 
summary, contraceptive prevalence was higher for all methods in PRAMS except for 
implants.  
There are several limitations to using Medicaid contraceptive claims data. 
First and foremost, we were not able to identify contraceptives that did not get billed 
to Medicaid such as condoms or withdrawal. Medicaid claims data only capture 
receipt of contraception not actual use. Thus there is a potential for women to be 
classified as receiving a contraceptive method but they may not be using it at the 
time indicated on the claim. Furthermore, we did not assess method discontinuation. 
Our analysis does not account for IUC expulsions, which may be between 2% and 
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10% during the first year after insertion.127,128 Additionally, 0.25% of the sample had 
a removal claim for an implant or IUC in the 90-day period, and we continued to 
classify them as receiving contraception and receiving the most effective methods 
even if they had no other claims or claims for a less-effective method. We did not 
reclassify them because our question of interest was PTB in relation to the methods 
women received in the 90-day period. Thus we may be slightly overestimating 
contraceptive receipt and effectiveness for these methods. Finally, claims data may 
be subject to billing errors. 
Considering these limitations, overall our contraceptive prevalence is likely 
underestimated and may overstate the level of risk for a short IPI or unintended 
pregnancy because a portion of women classified as not receiving contraception or 
less effective methods may be using methods not billed by Medicaid. This could lead 
to misclassification, such that women with a recent PTB may appear less likely to 
receive contraception, but it may not accurately reflect their actual use.  
Additionally, obstetric estimate (OE) of gestation was used as our exposure 
measure. Several studies have examined the validity of obstetric estimate since its 
addition to the 2003 revision of the birth certificate and concluded that OE may 
undercount the rate of PTB.76–80 We acknowledge that OE may underestimate PTB 
and make our estimate of PTB look better than the national prevalence based on 
last menstrual period (LMP) calculated by the National Center for Health Statistics 
(NCHS), but we use it because LMP was missing more observations in our sample 
and LMP has its own limitations.78,79 We excluded 6% of women missing data, 
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mostly on pregnancy intentions, but sensitivity analysis generated effect measures 
similar to those of the main analysis.  
Finally, our analysis was only conducted among pregnant women screened 
by the PMH program, which was just over half of the Medicaid deliveries that were 
matched to birth certificates during that time period. Excluding women not screened 
by the program limits our generalizability but allowed us to control for novel risk 
factors from the PMH risk screen and provide baseline information for the PMH 
program.  
This research makes an important contribution in an understudied area of 
PTB prevention. We documented that women with a recent PTB were less likely to 
receive any contraception or the most effective methods than women with term 
infants, though differences were minimal and appeared to matter more for women 
who had more than two children. More importantly, we found that only half of women 
with a recent PTB received any contraception and one-quarter received the most 
effective methods. Even if this underestimates actual contraceptive use, it suggests 
that a sizeable proportion of low-income postpartum women at high risk for PTB in 
NC are at risk for unintended pregnancy and short interpregnancy intervals. Our 
study cannot determine the reasons for the low levels of contraceptive receipt (e.g., 
low patient demand or insufficiently trained providers), but it suggests that increased 
attention to the provision of effective methods of postpartum contraception in publicly 
funded programs is needed, particularly for women with a recent PTB, for further 
reductions in preterm birth to be realized. 
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Figure 3.1. Analysis sample.  
 
  
 
- 49% (n=33,852) no risk screening conducted
- 1.6% (n=554) duplicate or inactive risk screen
- 0.04% (n=13) Emergency Medicaid
-0.31% (n=108) gestational age at birth < 24 weeks
-0.07% (n=25) hysterectomy
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n = 35,399
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n = 34,845
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n = 32,647
At risk for pregnancy
n = 34,699
With prenatal Medicaid Coverage
n = 34,832
n = 34,724
Gestational age at birth > 24 weeks
 Figure 3.2. Conceptual model depicting hypothesized relationships among preterm birth, parity, and postpartum 
contraception. 
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Table 3.1.  
 
Sociodemographic, Health, and Access Characteristics of Women Screened by the 
Pregnancy Medical Home Program, Stratified by Preterm Birth (n=32,647) 
 
Term Preterm Total 
37–42 weeks 24–36 weeks 
N % N % N p-value* 
Sociodemographic Characteristics 
Age at Delivery 0.0001
<18 3056 90.49 321 9.51 3377 
19-34 24729 89.99 2750 10.01 27479 
>35 1557 86.93 234 13.07 1791 
Race/Ethnicity 0.0001
Non-Hispanic White 13807 91.02 1363 8.98 15170 
Non-Hispanic Black 11436 87.81 1587 12.19 13023 
Asian/Pacific Islander 687 91.97 60 8.03 747 
American Indian/Alaska Native 836 91.27 80 8.73 916 
Hispanic 2338 92.56 188 7.44 2526 
Other 238 89.81 27 10.19 265 
U.S. Born  0.0001
No 2015 92.81 156 7.19 2171 
Yes 27327 89.67 3149 10.33 30476 
Married at Conception or Birth  0.0001
No 20673 89.24 2492 10.76 23165 
Yes 8669 91.43 813 8.57 9482 
Education Level 0.355
Less than high school 7653 89.44 904 10.56 8557 
High school grad/GED 10214 90.12 1120 9.88 11334 
Some college/Assoc degree 10045 89.88 1131 10.12 11176 
College grad or higher 1430 90.51 150 9.49 1580 
Reproductive Health Characteristics 
Parity 0.0001
< 2 births 21211 90.58 2207 9.42 23418 
More than 2 births 8131 88.10 1098 11.90 9229 
Pregnancy Intention 0.0001
Intended (Now/Sooner) 7710 90.78 783 9.22 8493 
Mistimed (Later) 13095 90.58 1362 9.42 14457 
Unwanted (Never) 3132 88.03 426 11.97 3558 
Don't know 5405 88.04 734 11.96 6139 
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Short Interpregnancy Interval (< 12 months) 0.001
No 27751 90.01 3079 9.99 30830 
Yes 1591 87.56 226 12.44 1817 
Preterm Birth History 0.0001
No 27504 91.07 2697 8.93 30201 
Yes 1838 75.14 608 24.86 2446 
Low Birth Weight History 0.0001
No 28878 90.17 3147 9.83 32025 
Yes 464 74.60 158 25.40 622 
Breastfeeding at Discharge 0.0001
No 11751 88.62 1509 11.38 13256 
Yes 17591 90.74 1795 9.26 19391 
Chronic Health Conditions 
Body Mass Index 0.0001
Underweight 1174 86.32 186 13.68 1360 
Normal 10852 89.83 1228 10.17 12080 
Overweight 7336 90.45 775 9.55 8111 
Obese 9980 89.94 1116 10.06 11096 
Diabetes 0.0001
No 28959 90.09 3187 9.91 32146 
Yes 383 76.45 118 23.55 501 
Hypertension 0.0001
No 28604 90.29 3077 9.71 31681 
Yes 738 76.40 228 23.60 966 
Access Characteristics 
Medicaid for Pregnant Women 0.0001
No 10164 88.40 1334 11.60 11498 
Yes 19178 90.68 1971 9.32 21149 
Delayed Prenatal Care 0.005
No 22392 89.61 2595 10.39 24987 
Yes 6950 90.73 710 9.27 7660 
Non-English Speaking 0.004
No 28802 89.81 3267 10.19 32069 
Yes 540 93.43 38 6.57 578 
Rurality 0.044
Metropolitan 19687 89.59 2288 10.41 21975 
Micropolitan 7390 90.52 774 9.48 8164 
Rural 2265 90.31 243 9.69 2508 
Sample size (n) 29342 89.88 3305 10.12 32647   
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to December 31, 2012 
N = frequency; % = percent. *p-value from the Pearson chi-square test. 
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Table 3.2.  
 
Sociodemographic, Health, and Access Characteristics of Women Screened by the 
Pregnancy Medical Home Program, Stratified by Receipt of Contraception 90 Days after 
Delivery (n=32,647) 
 
Receipt of Contraception Total 
No Yes 
N % N % N p-value* 
Sociodemographic 
Characteristics 
Age at Delivery 0.0001
<18 1495 44.27 1882 55.73 3377 
19-34 13268 48.28 14211 51.72 27479 
>35 939 52.43 852 47.57 1791 
Race/Ethnicity 0.0001
Non-Hispanic White 6878 45.34 8292 54.66 15170 
Non-Hispanic Black 6584 50.56 6439 49.44 13023 
Asian/Pacific Islander 430 57.56 317 42.44 747 
American Indian/Alaska Native 417 45.52 499 54.48 916 
Hispanic 1254 49.64 1272 50.36 2526 
Other 139 52.45 126 47.55 265 
U.S. Born  0.0001
No 1191 54.86 980 45.14 2171 
Yes 14511 47.61 15965 52.39 30476 
Married at Conception or Birth  0.373
No 11178 48.25 11987 51.75 23165 
Yes 4524 47.71 4958 52.29 9482 
Education Level 0.0001
Less than high school 4426 51.72 4131 48.28 8557 
High school grad/GED 5376 47.43 5958 52.57 11334 
Some college/Assoc degree 5097 45.61 6079 54.39 11176 
College grad or higher 803 50.82 777 49.18 1580 
Reproductive Health 
Characteristics 
Parity 0.0001
< 2 births 11023 47.07 12395 52.93 23415 
More than 2 births 4679 50.70 4550 49.30 9232 
Pregnancy Intention 0.0001
Intended (Now/Sooner) 4171 49.11 4322 50.89 8493 
Mistimed (Later) 6666 46.11 7791 53.89 14457 
Unwanted (Never) 1773 49.83 1785 50.17 3558 
Don't know 3092 50.37 3047 49.63 6139 
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Short Interpregnancy Interval (< 12 
months) 0.059
No 14789 47.97 16041 52.03 30830 
Yes 913 50.25 904 49.75 1817 
Preterm Birth History 0.001
No 14447 47.84 15754 52.16 30201 
Yes 1255 51.31 1191 48.69 2446 
Low Birth Weight History 0.0001
No 15355 47.95 16670 52.05 32025 
Yes 347 55.79 275 44.21 622 
Breastfeeding at Discharge 0.014
No 6487 48.92 6773 51.08 13260 
Yes 9215 47.53 10172 52.47 19387 
Chronic Health Conditions 
Body Mass Index 0.0001
Underweight 707 51.99 653 48.01 1360 
Normal 5959 49.33 6121 50.67 12080 
Overweight 3909 48.19 4202 51.81 8111 
Obese 5127 46.21 5969 53.79 11096 
Diabetes 0.469
No 15453 48.07 16693 51.93 32146 
Yes 249 49.70 252 50.30 501 
Hypertension 0.256
No 15220 48.04 16461 51.96 31681 
Yes 482 49.90 484 50.10 966 
Access Characteristics 
Medicaid for Pregnant Women 0.0001
No 5781 50.28 5717 49.72 11498 
Yes 9921 46.91 11228 53.09 21149 
Delayed Prenatal Care 0.0001
No 11519 46.10 13468 53.90 24987 
Yes 4183 54.61 3477 45.39 7660 
Non-English Speaking 0.0001
No 15362 47.90 16707 52.10 32069 
Yes 340 58.82 238 41.18 578 
Rurality 0.0001
Metropolitan 10877 49.50 11098 50.50 21975 
Micropolitan 3724 45.61 4440 54.39 8164 
Rural 1101 43.90 1407 56.10 2508 
Sample size (n) 15702 48.10 16945 51.90 32647   
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to December 31, 2012 
N = frequency; % = percent. *p-value from the Pearson chi-square test.
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Table 3.3.  
 
Receipt of Contraception, Method Type, and Effectiveness 90 Days after Delivery of Women 
Screened by the Pregnancy Medical Home Program, Stratified by Preterm Birth (n=32,647) 
 
Term Preterm Total 
37–42 weeks 24–36 weeks
N % N % N % p-value* 
Receipt of 
Contraception 0.018
No 14048 47.88 1654 50.05 15702 48.10 
Yes 15294 52.12 1651 49.95 16945 51.90 
Contraceptive 
Methods* 
Tubal Ligation/Essure 
Procedure 0.241
No 26855 91.52 3005 90.92 29860 91.46 
Yes 2487 8.48 300 9.08 2787 8.54 
Intrauterine contraception (IUC) 0.0001
No 25205 85.90 2932 88.71 28137 86.19 
Yes 4137 14.10 373 11.29 4510 13.81 
Implant 0.383
No 27781 94.68 3141 95.04 30922 94.72 
Yes 1561 5.32 164 4.96 1725 5.28 
Oral Contraceptive 0.142
No 24832 84.63 2829 85.60 27661 84.73 
Yes 4510 15.37 474 14.40 4988 15.28 
Injectable 0.002
No 26693 90.97 2953 89.35 29646 90.81 
Yes 2649 9.03 352 10.65 3001 9.19 
Patch 0.539
No 29052 99.01 3276 99.12 32328 99.02 
Yes 290 0.99 29 0.88 319 0.98 
Ring 0.184
No 29026 98.92 3261 98.67 32287 98.90 
Yes 316 1.08 44 1.33 360 1.10 
Diaphragm 0.288
No 29332 99.97 3305 100 32637 99.97 
Yes 10 0.03 0 0.00 10 0.03 
Long-acting Reversible† (LARC) 0.0001
No 23651 80.60 2769 83.78 26420 80.93 
Yes 5691 19.40 536 16.22 6227 19.07 
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Effectiveness tier†† 0.006
Less 14048 47.88 1654 50.05 15702 48.10 
Moderate 7123 24.27 814 24.66 7936 24.31 
Most 8173 27.85 836 25.30 9009 27.60 
Sample size (n) 29342 89.88 3305 10.12 32647 100.00   
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to December 31, 2012 
N = frequency;  % = percent. p-value from the Pearson chi-square test. *Women who received 
more than one method type were counted in each of the methods received.  
†Long-acting reversible includes implant and intrauterine contraception.  
††Less effective refers to no contraceptive Medicaid claim within 90 days of delivery. Moderate 
refers to injectable, patch, ring, oral contraceptive, and diaphragm. Most effective refers to tubal 
ligation, implant, intrauterine contraception. Women with more than one method were classified in 
the tier of the most effective method.
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Table 3.4.  
 
Crude and Adjusted Odds Ratios for Sociodemographic, Health, and Access Characteristics 
and Receipt of Contraception 90 Days after Delivery among Women Screened by the 
Pregnancy Medical Home Program (n=32,647) 
 
Contraception 
  
Crude 
OR (95% CI) p 
Adj. 
OR (95% CI) p 
Preterm Birth most 
recent delivery 
No --- ---
Yes 0.92 (0.85,0.99) ** 
Parity 
< 2 births --- --- --- ---
More than 2 births 0.86 (0.82, 0.91) *** --- ---
Interaction preterm 
birth*parity 
< 2 births & full term --- --- --- ---
< 2 births & preterm --- --- 1.01 (0.92, 1.10)
>2 births & full term --- --- --- ---
> 2 births & preterm --- --- 0.84 (0.74, 0.96) ** 
Sociodemographic 
Characteristics 
Age at Delivery 
<18 1.18 (1.09, 1.26) *** 1.35 (1.25, 1.47) ***
19–34 --- --- --- ---
>35 0.85 (0.77, 0.93) *** 0.88 (0.80, 0.98) ** 
Race/Ethnicity 
Non-Hispanic White  --- --- --- ---
Non-Hispanic Black 0.81 (0.77, 0.85) *** 0.84 (0.80, 0.88) ***
Asian/Pacific Islander 0.61 (0.53, 0.71) *** 0.79 (0.67, 0.94) ***
American 
Indian/Alaska Native 0.99 (0.87, 1.13) 0.96 (0.83, 1.10)
Hispanic 0.84 (0.77, 0.92) *** 0.91 (0.83, 1.00) ** 
Other 0.75 (0.59, 0.96) ** 0.91 (0.71, 1.17)
U.S. Born  
No --- --- --- ---
Yes 1.34 (1.23, 1.46) *** 1.12 (1.00, 1.25) * 
Married at Conception 
or Birth  
No --- --- --- ---
Yes 1.02 (0.97, 1.07) 1.01 (0.95, 1.06)
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Education Level 
Less than high school --- --- --- ---
High school grad/GED 1.19 (1.12, 1.26) *** 1.18 (1.12, 1.26) ***
Some college/Assoc 
degree 1.28 (1.21, 1.35) *** 1.28 (1.20, 1.36) ***
College grad or higher 1.04 (0.93, 1.15) 1.06 (0.94, 1.19)
Reproductive Health 
Characteristics 
Pregnancy Intention 
Intended 
(Now/Sooner) --- --- --- ---
Mistimed (Later) 1.13 (1.07, 1.19) *** 1.16 (1.09, 1.23) ***
Unwanted (Never) 0.97 (0.90, 1.05) 1.10 (1.01, 1.20) ** 
Don't know 0.95 (0.89, 1.02) 1.01 (0.95, 1.09)
Short Interpregnancy  
Interval (< 12 months) 
No --- --- --- ---
Yes 0.91 (0.83, 1.00) * 0.98 (0.89, 1.08)
Preterm Birth History 
No --- --- --- ---
Yes 0.87 (0.80, 0.95) *** 0.99 (0.90, 1.08)
Low Birth Weight 
History 
No --- --- --- ---
Yes 0.73 (0.62, 0.86) *** 0.85 (0.71, 1.01) * 
Breastfeeding at 
Discharge 
No --- --- --- ---
Yes 1.06 (1.01, 1.10) ** 1.01 (0.97, 1.06)
Chronic Health 
Conditions 
Body Mass Index 
Underweight 0.90 (0.80, 1.01) * 0.89 (0.80, 1.00) ** 
Normal --- --- --- ---
Overweight 1.05 (0.99, 1.11) 1.07 (1.01, 1.13) ** 
Obese 1.13 (1.08, 1.19) *** 1.17 (1.11, 1.23) ***
Diabetes 
No --- --- --- ---
Yes 0.94 (0.79, 1.12) 0.93 (0.77, 1.11)
Hypertension 
No --- --- --- ---
Yes 0.93 (0.82, 1.06) 0.94 (0.83, 1.08)
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Access Characteristics 
Medicaid for Pregnant 
Women 
No --- --- --- ---
Yes 1.14 (1.09, 1.20) *** 1.11 (1.05, 1.16) ***
Delayed Prenatal Care 
No --- --- --- ---
Yes 0.71 (0.68, 0.75) *** 0.75 (0.71, 0.79) ***
Non-English Speaking 
No --- --- --- ---
Yes 0.64 (0.54, 0.76) *** 0.91 (0.75, 1.10)
Rurality 
Metropolitan --- --- --- ---
Micropolitan 1.17 (1.11, 1.23) *** 1.10 (1.04, 1.16) ***
Rural 1.25 (1.15, 1.36) *** 1.15 (1.05, 1.25) ***
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011 to December 31, 2012. *p<0.1, 
**p<0.05,***p<0.01, OR = odds ratio, CI = confidence interval, Adj. = Adjusted 
 
 
  
 
 
  
Table 3.5. Crude and Adjusted Odds Ratios for Sociodemographic, Health, and Access Characteristics and Method Effectiveness Tier 90 
Days after Delivery among Women Screened by the Pregnancy Medical Home Program (n=32,647)
Crude OR p Crude OR p Adj. OR p Adj. OR p
Preterm Birth most recent delivery
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.97 (0.89 , 1.06) 0.87 (0.80 , 0.95) *** 1.03 (0.94 , 1.13) 0.89 (0.81 , 0.97) **
Sociodemographic Characteristics
Age at Delivery
<18 1.48 (1.36 , 1.61) *** 0.91 (0.83 , 1.00) ** 1.45 (1.31 , 1.59) *** 1.21 (1.09 , 1.34) ***
19-34 --- --- --- --- --- --- --- --- --- --- --- ---
>35 0.61 (0.53 , 0.70) *** 1.05 (0.94 , 1.17) 0.75 (0.65 , 0.86) *** 0.97 (0.86 , 1.09)
Race/Ethnicity
Non-Hispanic White --- --- --- --- --- --- --- --- --- --- --- ---
Non-Hispanic Black 1.02 (0.96 , 1.08) 0.66 (0.62 , 0.69) *** 1.13 (1.06 , 1.20) *** 0.64 (0.60 , 0.68) ***
Asian/Pacific Islander 0.79 (0.66 , 0.95) ** 0.48 (0.40 , 0.58) *** 1.00 (0.81 , 1.23) 0.64 (0.52 , 0.79) ***
American Indian/Alaska Native 0.99 (0.83 , 1.17) 1.00 (0.85 , 1.16) 0.96 (0.81 , 1.15) 0.95 (0.81 , 1.11)
Hispanic 0.87 (0.78 , 0.97) ** 0.82 (0.74 , 0.90) *** 0.94 (0.83 , 1.05) 0.89 (0.80 , 0.99) **
Other 0.73 (0.53 , 1.01) * 0.77 (0.58 , 1.02) * 0.90 (0.65 , 1.25) 0.92 (0.68 , 1.23)
U.S. Born 
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.36 (1.22 , 1.52) *** 1.32 (1.19 , 1.47) *** 1.17 (1.02 , 1.36) ** 1.08 (0.94 , 1.23)
Married at Conception or Birth 
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.85 (0.80 , 0.90) *** 1.19 (1.12 , 1.26) *** 0.95 (0.89 , 1.02) 1.05 (0.98 , 1.12)
Education Level
Less than high school --- --- --- --- --- --- --- --- --- --- --- ---
High school grad/GED 1.09 (1.01 , 1.16) ** 1.29 (1.21 , 1.38) *** 1.10 (1.02 , 1.18) ** 1.27 (1.18 , 1.37) ***
Some college/Assoc degree 1.14 (1.06 , 1.22) *** 1.42 (1.32 , 1.52) *** 1.17 (1.08 , 1.26) *** 1.38 (1.28 , 1.49) ***
College grad or higher 1.01 (0.88 , 1.15) 1.07 (0.94 , 1.22) 1.05 (0.91 , 1.21) 1.07 (0.93 , 1.23)
Moderately Effective
(95% CI)
Moderately Effective
(95% CI)
Most Effective
(95% CI)
Most Effective
(95% CI)
100 
  
Reproductive Health Characteristics
Parity
< 2 births --- --- --- --- --- --- --- --- --- --- --- ---
More than 2 births 0.55 (0.51 , 0.58) *** 1.21 (1.14 , 1.28) *** 0.66 (0.61 , 0.71) *** 1.26 (1.18 , 1.34) ***
Pregnancy Intention
Intended (Now/Sooner) --- --- --- --- --- --- --- --- --- --- --- ---
Mistimed (Later) 1.07 (1.00 , 1.14) ** 1.19 (1.11 , 1.26) *** 0.98 (0.91 , 1.05) 1.34 (1.25 , 1.44) ***
Unwanted (Never) 0.68 (0.61 , 0.75) *** 1.27 (1.16 , 1.39) *** 0.74 (0.67 , 0.83) *** 1.48 (1.35 , 1.63) ***
Don't know 0.88 (0.81 , 0.96) *** 1.02 (0.94 , 1.11) 0.88 (0.81 , 0.96) *** 1.14 (1.05 , 1.24) ***
Short Interpregnancy Interval (< 12 months)
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.69 (0.61 , 0.79) *** 1.11 (1.00 , 1.24) * 0.83 (0.72 , 0.94) *** 1.10 (0.99 , 1.23) *
Preterm Birth History
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.68 (0.61 , 0.76) *** 1.04 (0.95 , 1.14) 0.90 (0.79 , 1.01) * 1.05 (0.94 , 1.16)
Low Birth Weight History
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.59 (0.47 , 0.73) *** 0.86 (0.71 , 1.03) 0.80 (0.63 , 1.01) * 0.88 (0.72 , 1.07)
Breastfeeding at Discharge
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.07 (1.02 , 1.13) ** 1.04 (0.99 , 1.10) 1.03 (0.97 , 1.09) 1.00 (0.95 , 1.06)
Chronic Health Conditions
Body Mass Index
Underweight 0.98 (0.86 , 1.12) 0.81 (0.70 , 0.94) *** 0.97 (0.85 , 1.11) 0.81 (0.70 , 0.94) ***
Normal --- --- --- --- --- --- --- --- --- --- --- ---
Overweight 0.94 (0.88 , 1.01) 1.16 (1.08 , 1.24) *** 0.98 (0.92 , 1.06) 1.16 (1.08 , 1.24) ***
Obese 0.92 (0.86 , 0.98) *** 1.36 (1.28 , 1.45) *** 0.98 (0.91 , 1.05) 1.36 (1.28 , 1.46) ***
Diabetes
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.89 (0.71 , 1.11) 0.98 (0.80 , 1.21) 1.00 (0.80 , 1.26) 0.87 (0.70 , 1.08)
Hypertension
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.68 (0.57 , 0.81) *** 1.15 (1.00 , 1.33) * 0.76 (0.63 , 0.91) *** 1.09 (0.93 , 1.26)
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Access Characteristics
Medicaid for Pregnant Women
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.10 (1.04 , 1.17) *** 1.18 (1.12 , 1.25) *** 1.10 (1.03 , 1.17) *** 1.12 (1.05 , 1.19) ***
Delayed Prenatal Care
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.74 (0.70 , 0.79) *** 0.68 (0.64 , 0.73) *** 0.78 (0.73 , 0.84) *** 0.72 (0.67 , 0.77) ***
Non-English Speaking
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.70 (0.57 , 0.86) *** 0.59 (0.48 , 0.73) *** 1.00 (0.78 , 1.27) 0.83 (0.65 , 1.06)
Rurality
Metropolitan --- --- --- --- --- --- --- --- --- --- --- ---
Micropolitan 1.10 (1.03 , 1.18) *** 1.23 (1.16 , 1.30) *** 1.09 (1.02 , 1.16) ** 1.10 (1.04 , 1.18) ***
Rural 1.32 (1.19 , 1.46) *** 1.19 (1.08 , 1.32) *** 1.27 (1.15 , 1.41) *** 1.04 (0.94 , 1.15)
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth Records, and Medicaid Claims Data from September 1, 
2011 to December 31, 2012. Moderately effective includes diaphragm, injections, patch, ring and oral contraceptives. Most effective includes tubal
ligation, implant, and IUD. Referent group is no contraceptive claim. *p<0.1, **p<0.05, ***p<0.01, OR = odds ratio, CI = confidence interval. Adj. = adjusted
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Table 3.6.  
 
Sociodemographic, Health, and Access Characteristics of Women Screened by the 
Pregnancy Medical Home Program, Stratified by Very Preterm Birth (n=32,647) 
 
Mod. PTB or 
Term Very Preterm Total 
32–42 weeks 24–31 weeks 
N % N % N p-value* 
Sociodemographic 
Characteristics 
Age at Delivery 0.936
<18 3316 98.19 61 1.81 3377 
19-34 26988 98.21 491 1.79 27479 
>35 1761 98.32 30 1.68 1791 
Race/Ethnicity 0.0001
Non-Hispanic White 14964 98.64 206 1.36 15170 
Non-Hispanic Black 12701 97.53 322 2.47 13023 
Asian/Pacific Islander 740 99.06 7 0.94 747 
American Indian/Alaska Native 900 98.25 16 1.75 916 
Hispanic 2499 98.93 27 1.07 2526 
Other 261 98.49 4 1.51 265 
U.S. Born  0.005
No 2149 98.99 22 1.01 2171 
Yes 29916 98.16 560 1.84 30476 
Married at Conception or Birth  0.0001
No 22697 97.98 468 2.02 23165 
Yes 9368 98.80 114 1.20 9482 
Education Level 0.855
Less than high school 8411 98.29 146 1.71 8557 
High school grad/GED 11124 98.15 210 1.85 11334 
Some college/Assoc degree 10976 98.21 200 1.79 11176 
College grad or higher 1554 98.35 26 1.65 1580 
Reproductive Health 
Characteristics 
Parity 0.209
< 2 births 22987 98.16 431 1.84 23418 
More than 2 births 9078 98.36 151 1.64 9229 
Pregnancy Intention 0.193
Intended (Now/Sooner) 8359 98.42 134 1.58 8493 
Mistimed (Later) 14203 98.24 254 1.76 14457 
Unwanted (Never) 3487 98.00 71 2.00 3558 
Don't know 6016 98.00 123 2.00 6139 
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Short Interpregnancy Interval (< 12 
months) 0.165
No 30288 98.24 542 1.76 30830 
Yes 1777 97.80 40 2.20 1817 
Preterm Birth History 0.0001
No 29729 98.44 472 1.56 30201 
Yes 2336 95.50 110 4.50 2446 
Low Birth Weight History 0.0001
No 31475 98.28 550 1.72 32025 
Yes 590 94.86 32 5.14 622 
Breastfeeding at Discharge 0.646
No 13029 98.26 231 1.74 13260 
Yes 19036 98.19 351 1.81 19387 
Chronic Health Conditions 
Body Mass Index 0.416
Underweight 1332 97.94 28 2.06 1360 
Normal 11878 98.33 202 1.67 12080 
Overweight 7972 98.29 139 1.71 8111 
Obese 10883 98.08 213 1.92 11096 
Diabetes 0.0001
No 31585 98.25 561 1.75 32146 
Yes 480 95.81 21 4.19 501 
Hypertension 0.0001
No 31144 98.30 537 1.70 31681 
Yes 921 95.34 45 4.66 966 
Access Characteristics 
Medicaid for Pregnant Women 0.002
No 11257 97.90 241 2.10 11498 
Yes 20808 98.39 341 1.61 21149 
Delayed Prenatal Care 0.026
No 24519 98.13 468 1.87 24987 
Yes 7546 98.51 114 1.49 7660 
Non-English Speaking 0.046
No 31491 98.20 578 1.80 32069 
Yes 574 99.31 4 0.69 578 
Rurality 0.047
Metropolitan 21556 98.09 419 1.91 21975 
Micropolitan 8042 98.51 122 1.49 8164 
Rural 2467 98.37 41 1.63 2508 
Sample size (n) 32065 98.22 582 1.78 32647   
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to December 31, 2012 
N = frequency; % = percent. *p-value from the Pearson chi-square test. 
  
105 
Table 3.7.  
 
Receipt of Contraception, Method Type, and Effectiveness 90 Days after Delivery among 
Women Screened by the Pregnancy Medical Home Program, Stratified by Very Preterm 
Birth (n=32,647) 
 
Mod. PTB or 
Term 
Very 
Preterm Total 
32–42 weeks 
24–31 
weeks 
N % N % N % p-value* 
Receipt of 
Contraception 0.009
No 15391 48.00 311 53.44 15702 48.10 
Yes 16674 52.00 271 46.56 16945 51.90 
Contraceptive 
Methods* 
Tubal Ligation/Essure 
Procedure 0.001
No 29306 91.40 554 95.19 29860 91.46 
Yes 2759 8.60 28 4.81 2787 8.54 
Intrauterine contraception 
(IUC) 0.001
No 27609 86.10 528 90.72 28137 86.19 
Yes 4456 13.90 54 9.28 4510 13.81 
Implant 0.010
No 30357 94.67 565 97.08 30922 94.72 
Yes 1708 5.33 17 2.92 1725 5.28 
Oral Contraceptive 0.035
No 27186 84.78 475 81.62 27661 84.73 
Yes 4879 15.22 107 18.38 4986 15.27 
Injectable 0.051
No 29131 90.85 515 88.49 29646 90.81 
Yes 2934 9.15 67 11.51 3001 9.19 
Patch 0.067
No 31756 99.04 572 98.28 32328 99.02 
Yes 309 0.96 10 1.72 319 0.98 
Ring 0.867
No 31711 98.90 576 98.97 32287 98.90 
Yes 354 1.10 6 1.03 360 1.10 
Diaphragm 0.670
No 32055 99.97 582 100 32637 99.97 
Yes 10 0.03 0 0.00 10 0.03 
  
106 
Long-acting Reversible† 
(LARC) 0.0001
No 25908 80.80 512 87.97 26420 80.93 
Yes 6157 19.20 70 12.03 6227 19.07 
Effectiveness tier†† 0.0001
Less 15391 48.00 311 53.44 15702 48.10 
Moderate 7763 24.21 173 29.73 7936 24.31 
Most 8911 27.79 98 16.84 9009 27.60 
Sample size (n) 32065 98.22 582 1.78 32647 100.00   
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011, to December 31, 2012. 
N = frequency;  % = percent. p-value from the Pearson chi-square test.  
*Women who received more than one method type were counted in all of the methods received. 
†Long-acting reversible includes implant and intrauterine contraception.  
††Less effective refers to no contraceptive Medicaid claim within 90 days of delivery. Moderate 
refers to injectable, patch, ring, oral contraceptive, and diaphragm. Most effective refers to tubal 
ligation, implant, intrauterine contraception. Women with more than one method were classified in 
the tier of the most effective method.
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Table 3.8.  
 
Crude and Adjusted Odds Ratios for Sociodemographic, Health, and Access Characteristics 
and Receipt of Contraception 90 Days after Delivery among Women Screened by the 
Pregnancy Medical Home Program (n=32,647) 
 
Contraception 
Crude 
OR (95% CI) p Adj. OR (95% CI) p 
Very Preterm Birth Most Recent 
Delivery 
No --- ---
Yes 0.80 (0.68, 0.95) ***
Parity 
< 2 births --- --- --- ---
More than 2 births 0.86 (0.82, 0.91) *** --- ---
Interaction very preterm 
birth*parity 
< 2 births & >= 32 
weeks --- --- --- ---
< 2 births & very 
preterm --- --- 0.89 (0.73, 1.08)
>2 births & >=32 weeks --- --- --- ---
> 2 births & very 
preterm --- --- 0.64 (0.46, 0.90) ** 
Sociodemographic 
Characteristics 
Age at Delivery 
<18 1.18 (1.09, 1.26) *** 1.35 (1.25, 1.47) ***
19-34 --- --- --- ---
>35 0.85 (0.77, 0.93) *** 0.88 (0.80, 0.97) ***
Race/Ethnicity 
Non-Hispanic White  --- --- --- ---
Non-Hispanic Black 0.81 (0.77, 0.85) *** 0.84 (0.79, 0.88) ***
Asian/Pacific Islander 0.61 (0.53, 0.71) *** 0.79 (0.67, 0.94) ***
American Indian/Alaska 
Native 0.99 (0.87, 1.13) 0.96 (0.84, 1.10)
Hispanic 0.84 (0.77, 0.92) *** 0.91 (0.83, 1.00) ** 
Other 0.75 (0.59, 0.96) ** 0.91 (0.71, 1.17)
U.S. Born  
No --- --- --- ---
Yes 1.34 (1.23, 1.46) *** 1.12 (1.00, 1.25) * 
Married at Conception 
or Birth  
No --- --- --- ---
Yes 1.02 (0.97, 1.07) 1.01 (0.95, 1.06)
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Education Level 
Less than high school --- --- --- ---
High school grad/GED 1.19 (1.12, 1.26) *** 1.19 (1.12, 1.26) ***
Some college/Assoc 
degree 1.28 (1.21, 1.35) *** 1.27 (1.20, 1.36) ***
College grad or higher 1.04 (0.93, 1.15) 1.06 (0.94, 1.19)
Reproductive Health 
Characteristics 
Pregnancy Intention 
Intended (Now/Sooner) --- --- --- ---
Mistimed (Later) 1.13 (1.07, 1.19) *** 1.16 (1.09, 1.23) ***
Unwanted (Never) 0.97 (0.90, 1.05) 1.10 (1.01, 1.20) ** 
Don't know 0.95 (0.89, 1.02) 1.01 (0.95, 1.09)
Short Interpregnancy Interval (< 12 months) 
No --- --- --- ---
Yes 0.91 (0.83, 1.00) * 0.98 (0.89, 1.08)
Preterm Birth History 
No --- --- --- ---
Yes 0.87 (0.80, 0.95) *** 0.98 (0.90, 1.07)
Low Birth Weight 
History 
No --- --- --- ---
Yes 0.73 (0.62, 0.86) *** 0.84 (0.71, 1.00) ** 
Breastfeeding at 
Discharge 
No --- --- --- ---
Yes 1.06 (1.01, 1.10) ** 1.02 (0.97, 1.06)
Chronic Health 
Conditions 
Body Mass Index 
Underweight 0.90 (0.80, 1.01) * 0.89 (0.80, 1.00) ** 
Normal --- --- --- ---
Overweight 1.05 (0.99, 1.11) 1.07 (1.01, 1.13) ** 
Obese 1.13 (1.08, 1.19) *** 1.17 (1.11, 1.23) ***
Diabetes 
No --- --- --- ---
Yes 0.94 (0.79, 1.12) 0.93 (0.77, 1.11)
Hypertension 
No --- --- --- ---
Yes 0.93 (0.82, 1.06) 0.94 (0.82, 1.08)
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Access 
Characteristics 
Medicaid for 
Pregnant Women 
No --- --- --- ---
Yes 1.14 (1.09, 1.20) *** 1.11 (1.05, 1.16) ***
Delayed Prenatal 
Care 
No --- --- --- ---
Yes 0.71 (0.68, 0.75) *** 0.75 (0.71, 0.79) ***
Non-English 
Speaking 
No --- --- --- ---
Yes 0.64 (0.54, 0.76) *** 0.91 (0.75, 1.10)
Rurality 
Metropolitan --- --- --- ---
Micropolitan 1.17 (1.11, 1.23) *** 1.10 (1.04, 1.16) ***
Rural 1.25 (1.15, 1.36) *** 1.15 (1.05, 1.25) ***
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth 
Records, and Medicaid Claims Data from September 1, 2011 to December 31, 2012. *p<0.1, 
**p<0.05, ***p<0.01, OR = odds ratio, CI = confidence interval, Adj. = Adjusted 
 
 
  
 
 
  
Table 3.9. Crude and Adjusted Odds Ratios for Sociodemographic, Health, and Access Characteristics and Method Effectiveness Tier 90 Days 
after Delivery among Women Screened by the Pregnancy Medical Home Program (n=32,647)
Crude OR p Crude OR p Adj. OR p Adj. OR p
Very Preterm Birth Most Recent Delivery
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.10 (0.91 , 1.33) 0.54 (0.43 , 0.68) *** 1.11 (0.92 , 1.34) 0.57 (0.45 , 0.71) ***
Sociodemographic Characteristics
Age at Delivery
<18 1.48 (1.36 , 1.61) *** 0.91 (0.83 , 1.00) ** 1.45 (1.31 , 1.59) *** 1.21 (1.09 , 1.34) ***
19-34 --- --- --- --- --- --- --- --- --- --- --- ---
>35 0.61 (0.53 , 0.70) *** 1.05 (0.94 , 1.17) 0.75 (0.65 , 0.86) *** 0.97 (0.86 , 1.08)
Race/Ethnicity
Non-Hispanic White --- --- --- --- --- --- --- --- --- --- --- ---
Non-Hispanic Black 1.02 (0.96 , 1.08) 0.66 (0.62 , 0.69) *** 1.13 (1.06 , 1.20) *** 0.64 (0.60 , 0.68) ***
Asian/Pacific Islander 0.79 (0.66 , 0.95) ** 0.48 (0.40 , 0.58) *** 1.00 (0.81 , 1.23) 0.64 (0.52 , 0.79) ***
American Indian/Alaska Native 0.99 (0.83 , 1.17) 1.00 (0.85 , 1.16) 0.96 (0.81 , 1.15) 0.95 (0.81 , 1.12)
Hispanic 0.87 (0.78 , 0.97) ** 0.82 (0.74 , 0.90) *** 0.94 (0.83 , 1.05) 0.89 (0.80 , 0.99) **
Other 0.73 (0.53 , 1.01) * 0.77 (0.58 , 1.02) * 0.90 (0.65 , 1.25) 0.92 (0.68 , 1.23)
U.S. Born 
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.36 (1.22 , 1.52) *** 1.32 (1.19 , 1.47) *** 1.17 (1.02 , 1.36) ** 1.07 (0.94 , 1.23)
Married at Conception or Birth 
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.85 (0.80 , 0.90) *** 1.19 (1.12 , 1.26) *** 0.95 (0.89 , 1.02) 1.05 (0.98 , 1.12)
Education Level
Less than high school --- --- --- --- --- --- --- --- --- --- --- ---
High school grad/GED 1.09 (1.01 , 1.16) ** 1.29 (1.21 , 1.38) *** 1.10 (1.02 , 1.18) ** 1.27 (1.18 , 1.37) ***
Some college/Assoc degree 1.14 (1.06 , 1.22) *** 1.42 (1.32 , 1.52) *** 1.17 (1.08 , 1.26) *** 1.38 (1.28 , 1.49) ***
College grad or higher 1.01 (0.88 , 1.15) 1.07 (0.94 , 1.22) 1.05 (0.91 , 1.21) 1.08 (0.93 , 1.23)
Moderately Effective Most Effective Moderately Effective Most Effective
(95% CI) (95% CI) (95% CI) (95% CI)
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Reproductive Health Characteristics
Parity
< 2 births --- --- --- --- --- --- --- --- --- --- --- ---
More than 2 births 0.55 (0.51 , 0.58) *** 1.21 (1.14 , 1.28) *** 0.66 (0.61 , 0.71) *** 1.25 (1.18 , 1.33) ***
Pregnancy Intention
Intended (Now/Sooner) --- --- --- --- --- --- --- --- --- --- --- ---
Mistimed (Later) 1.07 (1.00 , 1.14) ** 1.19 (1.11 , 1.26) *** 0.98 (0.91 , 1.05) 1.34 (1.25 , 1.44) ***
Unwanted (Never) 0.68 (0.61 , 0.75) *** 1.27 (1.16 , 1.39) *** 0.74 (0.67 , 0.83) *** 1.48 (1.35 , 1.63) ***
Don't know 0.88 (0.81 , 0.96) *** 1.02 (0.94 , 1.11) 0.88 (0.81 , 0.96) *** 1.14 (1.05 , 1.24) ***
Short Interpregnancy Interval (< 12 months)
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.69 (0.61 , 0.79) *** 1.11 (1.00 , 1.24) * 0.83 (0.72 , 0.94) *** 1.10 (0.99 , 1.23) *
Preterm Birth History
No --- --- --- --- --- ---
Yes 0.68 (0.61 , 0.76) *** 1.03 (0.95 , 1.14) 0.90 (0.80 , 1.01) * 1.04 (0.94 , 1.16)
Low Birth Weight History
No --- --- --- --- --- ---
Yes 0.59 (0.47 , 0.73) *** 0.86 (0.71 , 1.03) 0.80 (0.63 , 1.01) * 0.88 (0.72 , 1.07)
Breastfeeding at Discharge
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.07 (1.02 , 1.13) ** 1.04 (0.99 , 1.10) 1.03 (0.97 , 1.09) 1.00 (0.95 , 1.06)
Chronic Health Conditions
Body Mass Index
Underweight 0.98 (0.86 , 1.12) 0.81 (0.70 , 0.94) *** 0.97 (0.85 , 1.11) 0.81 (0.70 , 0.93) ***
Normal --- --- --- --- --- --- --- --- --- --- --- ---
Overweight 0.94 (0.88 , 1.01) 1.16 (1.08 , 1.24) *** 0.98 (0.92 , 1.05) 1.16 (1.08 , 1.24) ***
Obese 0.92 (0.86 , 0.98) *** 1.36 (1.28 , 1.45) *** 0.98 (0.91 , 1.04) 1.37 (1.28 , 1.46) ***
Diabetes
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.89 (0.71 , 1.11) 0.98 (0.80 , 1.21) 1.00 (0.80 , 1.27) 0.87 (0.70 , 1.08)
Hypertension
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.68 (0.57 , 0.81) *** 1.15 (1.00 , 1.33) * 0.76 (0.63 , 0.91) *** 1.09 (0.93 , 1.26)
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Access Characteristics
Medicaid for Pregnant Women
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 1.10 (1.04 , 1.17) *** 1.18 (1.12 , 1.25) *** 1.10 (1.03 , 1.17) *** 1.12 (1.05 , 1.19) ***
Delayed Prenatal Care
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.74 (0.70 , 0.79) *** 0.68 (0.64 , 0.73) *** 0.78 (0.73 , 0.84) *** 0.72 (0.67 , 0.77) ***
Non-English Speaking
No --- --- --- --- --- --- --- --- --- --- --- ---
Yes 0.70 (0.57 , 0.86) *** 0.59 (0.48 , 0.73) *** 1.00 (0.78 , 1.27) 0.83 (0.65 , 1.06)
Rurality
Metropolitan --- --- --- --- --- --- --- --- --- --- --- ---
Micropolitan 1.10 (1.03 , 1.18) *** 1.23 (1.16 , 1.30) *** 1.09 (1.02 , 1.16) ** 1.10 (1.04 , 1.18) ***
Rural 1.32 (1.19 , 1.46) *** 1.19 (1.08 , 1.32) *** 1.27 (1.15 , 1.41) *** 1.04 (0.94 , 1.15)
Source: Pregnancy Medical Home Case Management Information System, North Carolina Birth Records, and Medicaid Claims Data from September 1, 2011 to 
December 31, 2012. Moderately effective includes diaphragm, injections, patch, ring and oral contraceptives. Most effective includes tubal ligation, 
implant, and IUD. Referent group is no contraceptive claim. *p<0.1, **p<0.05, ***p<0.01, OR = odds ratio, CI = confidence interval. Adj. = adjusted112 
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CHAPTER 4. CONCLUSIONS 
OVERVIEW OF FINDINGS 
This dissertation evaluated Community Care of North Carolina’s Pregnancy 
Medical Home risk screening tool to determine which combination of risk factors was 
most predictive of preterm birth by parity and race/ethnicity (Chapter 2). The risk 
factors that were most predictive of PTB in this sample of Medicaid beneficiaries 
screened early in pregnancy include non-Hispanic black race, smoking during 
pregnancy, underweight, multi-fetal gestation, chronic disease (diabetes, 
hypertension, asthma, renal disease, and other chronic conditions), cervical 
insufficiency, nulliparity, and previous adverse reproductive outcomes (history of 
PTB, LBW baby, fetal death, and second trimester loss).  
Furthermore, several risk factors differed in relation to PTB based on parity 
and race/ethnicity. Obesity was associated with an increased risk of PTB among 
nulliparous women only, while food insecurity was associated with an increased risk 
of PTB among parous women only. A short IPI was associated with an increased 
risk of PTB for black women only; unsafe or unstable housing was associated with 
increased odds of PTB among white women only. 
This dissertation also compared receipt of postpartum contraception and 
method effectiveness among women with and without a recent preterm birth who 
were screened by the PMH program (Chapter 3). Women with a recent PTB who 
had more than two children had a lower likelihood of receiving any contraception, 
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particularly the most effective methods, compared to equal parity women who 
delivered at term. Among women who recently delivered preterm, contraceptive 
receipt was only 50% (and 25% for the most effective methods) at 90 days 
postpartum when two-thirds of the sample loses Medicaid coverage.  
Use of the Pregnancy Medical Home Risk Screen, Birth Certificates, and 
Medicaid Claims Data 
This dissertation takes advantage of extensive risk screening data from a 
novel program in North Carolina that has not been examined previously. 
Furthermore, it links this rich source of risk factor data to birth certificates and 
Medicaid claims. CCNC’s risk screen includes several psychosocial risk factors that 
have not been assessed before in relation to PTB while including important 
sociodemographic, current pregnancy, and obstetric history variables in the model. 
Although few of these psychosocial factors were significant in the final predictive 
model of PTB, they did show evidence of being important predictors of PTB among 
certain subpopulations. This level of detail of clinical risk factor data is not typically 
available on such a large and diverse sample of women on Medicaid identified early 
in pregnancy. Thus findings reported in Chapter 2 are more generalizable than the 
bulk of research on risk scoring systems for PTB that are based on smaller, clinic-
based convenience samples. Finally, prospective assessment of risk factors on the 
screening tool early in pregnancy, prior to the occurrence of the outcomes, provides 
for a stronger design compared to cross-sectional and retrospective studies.  
The analysis in Chapter 3 provides the first estimate of the relationship 
between PTB and postpartum contraceptive receipt. Linkage of risk factor data to 
birth certificates and Medicaid claims enabled inclusion of a wealth of control 
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variables to calculate the least biased estimate of contraceptive receipt by PTB 
status. The lower likelihood of receiving contraception among women who recently 
had a PTB remained significant even when adjusting for several sociodemographic, 
reproductive, and chronic health conditions and healthcare access variables.  
There are several limitations of these data. Because this was the first analysis 
to use the PMH risk screening form, the quality of the data was unknown and has 
not been validated. Several important variables were missing a substantial amount 
of data on the risk screening form and required substitution from the birth certificate. 
Numbers for current pregnancy characteristics were low for conditions that are often 
not detected until later in the pregnancy, such as hypertensive disorders of 
pregnancy, likely due to the screening cutoff prior to 24 weeks. The lower 
prevalence of these factors could lead to an underestimation of their effects, which 
could lead to the erroneous conclusion that these risk factors should not be 
prioritized even though they may be important contributors to PTB risk.  
Using Medicaid claims to assess contraception avoids the limitations of self-
reported data, which are the most common sources of contraceptive data in the 
United States from the NSFG and PRAMS. However, contraceptive claims data 
have several pitfalls, as were discussed in Chapter 3. Namely, Medicaid claims data 
only capture receipt of contraception, not actual use, and miss methods that cannot 
be billed such as condoms and withdrawal. It is not possible to determine whether 
women without a contraceptive claim are trying to get pregnant or not sexually active 
and therefore not in need of contraception. Furthermore, it remains unknown 
whether women obtain methods after 90 days. However given that 65% may lose 
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Medicaid coverage then, it is unlikely they would wait if they wanted it in the near 
future. Thus there may be misclassification bias due to women being classified as 
not receiving contraception when in reality they are using a less effective method 
that is not billable to Medicaid. Finally, though the risk screen provides a wealth of 
control variables to provide the least biased estimate of PTB and contraceptive 
receipt, it does not allow a test of the mechanisms through which PTB is inversely 
related to contraceptive receipt, which is important to inform intervention strategies.  
Contribution to the Literature on Risk Screening and Preterm Birth, Disparities 
in Birth Outcomes, and Interconception Health 
Risk assessment in PTB prevention has been hindered because many 
women who give birth preterm have no major risk factors.3 Also, a number of risk 
factors that are predictive of PTB, such as black race, are highly prevalent with a low 
relative risk.8 As such, previous risk scoring systems have only been able to identify 
a small proportion of women who have a PTB as high risk (low sensitivity), while a 
large proportion who have a PTB have been labeled as low risk (high false negative 
rate).21 Although the predictive model designed and internally validated from the 
PMH risk screening in this dissertation appears to perform slightly better than 
previous tools in terms of sensitivity, it still misses a large proportion of women who 
were identified as low risk by the model yet who go on to have a PTB (false 
negatives).  
These limitations suggest that different research methods are needed that 
better reflect the complexity of PTB parturition. One potential method is latent class 
analysis (LCA), which is a person-centered approach used to identify unobservable 
subgroups in a population.129 LCA could be used to identify groups of women 
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clustered by certain behaviors or co-occurring risk factors rather than individual risk 
factors. Results from LCA could translate more easily into the provision of more 
nuanced and holistic women’s health care, rather than current approaches of highly 
targeted programs for small groups of high-risk women that have evolved from 
research largely focused on parsing out individual risk factors.130 
Given the striking disparities in birth outcomes between NHB and NHW 
women, this analysis sought to identify risk factors that could be targeted specifically 
for care management among non-Hispanic black women. A short interpregnancy 
interval was the only risk factor that was associated with an increased PTB risk 
among black women but not white women. More research on obstacles to achieving 
healthy pregnancy spacing among black women is needed to inform interconception 
care strategies. 
 The analysis in Chapter 3 is the first to compare contraceptive receipt by PTB 
status. Women with a recent PTB were less likely to receive any contraception, 
particularly the most effective methods, which suggests that they are at increased 
risk for a short IPI, unintended pregnancy, and recurrent PTB. These findings 
support the call to prioritize interconception care provision to women with prior 
adverse pregnancy outcomes.31,32 The findings in Chapter 3 also support previous 
qualitative data on the difficulties low-income women face who may require multiple 
services in the postpartum period while trying to care for a preterm infant.31,68,99 More 
research is needed to understand the mechanisms through which a recent PTB may 
hinder receipt of contraception to better understand how to help women access it 
and achieve their reproductive plans.  
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Implications 
This study has several implications for practice and policy. Evaluation of risk 
factors from the PMH screening tool in Chapter 2 provides the evidence base to 
guide PMH program decision-making about which patients are most likely to deliver 
preterm and thus particularly warrant care management. The women who should be 
prioritized according to the final predictive model include those with the following risk 
factors: non-Hispanic black race, smoking during pregnancy, underweight, multi-fetal 
gestation, chronic disease (diabetes, hypertension, asthma, renal disease, and other 
chronic conditions), cervical insufficiency, nulliparity, and a history of PTB, low birth 
weight baby, fetal death, or second trimester loss.  
Additionally, salient risk factors for PTB were identified for certain subgroups 
that will guide prevention approaches for vulnerable populations and could promote 
equity in birth outcomes. These include a short IPI, food insecurity, obesity, and 
unsafe or unstable housing. For example, black women had a higher prevalence of 
both a history of PTB and a recent PTB, a higher risk of PTB associated with a short 
IPI, and a lower likelihood of receiving contraception or the most effective methods. 
Taken together, these findings highlight the need for care management for non-
Hispanic black women, particularly in the interconception period, to help optimize 
IPIs, avoid unintended pregnancy, and reduce the risk of recurrent PTB.  
This dissertation provides insight into how the PMH program can increase the 
sensitivity and specificity of their tool to reduce preterm births and associated costs 
by revising the list of currently prioritized risk factors based on variables in the final 
predictive model. Under the current prioritization scheme, each priority risk factor is 
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weighted the same such that a woman is referred for a care management 
assessment if she has any one of the priority risk factors. Weighting each risk factor 
according to its strength of association with PTB will reduce the number of women 
with a positive test so that resources can be funneled to those most in need of care 
management.  
It is also important to consider attributable risk rather than just relative risk.130 
For example, though multi-fetal gestations had the highest odds ratio for PTB in the 
final model, they were a relatively small proportion of the sample. Meanwhile, non-
Hispanic black race had a lower odds ratio, yet 40% of the sample is black. To 
impact PTB rates in the Medicaid population, resources will need to be directed to 
those risk factors with a larger attributable risk. This is tricky, however, because 
these risk factors make up a larger share of the population, which will result in more 
women being care managed. One solution is that the PMH program could adopt an 
algorithm to weight risk factors differently for certain subgroups by parity and 
race/ethnicity to reflect the higher risk of some factors for vulnerable subgroups. 
Before revisions to the risk screening tool are made, which would require 
amendment to Medicaid policy, similar analyses should be conducted using other 
important maternal and child health outcomes. Although the main objective of the 
PMH program is to reduce PTB, there are a host of outcomes (e.g., LBW) included 
in the larger program goal to improve birth outcomes and maternity care. Before 
changes in policy are made to adjust the composition of the priority population, other 
key outcomes should be examined.  
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For reductions in PTB to be realized, increased attention to the provision of 
effective methods of postpartum contraception in the PMH program is needed, 
particularly among women who recently had a PTB and have more than two 
children. Though this group of women is particularly in need of 
postpartum/interconception services given their increased vulnerability for a 
recurrent PTB, our findings in Chapter 3 suggest that they are less likely to receive 
any contraception within 90 days of delivery. Previous research documents that 
there may be missed opportunities for contraception dispensing in the postpartum 
period.83,97 In a recent study of women who received publicly funded healthcare 
services in California within 18 months of delivery, researchers calculated that there 
were 68,869 missed opportunities to dispense contraception; 59% of women did not 
obtain contraception despite accessing postpartum care.83 
In this dissertation it is not possible to determine the reasons why women with 
a recent PTB were less likely to receive contraception. Some literature suggests that 
women facing multiple burdens caring for a preterm infant may be less able to follow 
through on reproductive plans or attend postpartum visits.68,99,105 Or perhaps family 
planning is less of a priority for their providers who are busy addressing other health 
needs for these women and infants given their more complicated postnatal situation.  
Regardless, contraceptive counseling and method dispensing should be 
prioritized and extended for these women once they get past the initial demands of 
the early postpartum period. PMH care management is especially warranted for 
women with a recent PTB to assist in scheduling and attending the postpartum visit 
and connecting women who lose Medicaid coverage to the Family Planning Waiver.  
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This dissertation also provides evidence to support ongoing healthcare 
coverage for women who experience a preterm birth, such as through an 
Interconception Care Waiver that provides Medicaid coverage for an extended 
period of time beyond pregnancy to women with an adverse birth outcome. Most of 
the risk factors in the predictive model of PTB require monitoring and would benefit 
from follow-up beyond the prenatal period, such as smoking cessation, chronic 
disease management, and nutrition education. Furthermore, counseling about the 
need to prolong the IPI and supporting women to maintain continuous contraceptive 
coverage is especially needed in the interconception period for women with a recent 
PTB, LBW baby, fetal death, or second trimester loss.  
Though the main focus of this dissertation was on PTB prevention, it is 
important to acknowledge that poor birth outcomes and disparities in NC and the 
United States are largely a legacy of poor women’s health.130 All the women in this 
sample were living in poverty. The relationship between poverty, both at the 
individual and neighborhood level, and poor birth outcomes has been well 
established.75,131–134 In conclusion, the PMH program’s goal to improve maternity 
care and birth outcomes by intervening in the prenatal and 
postpartum/interconception period is just one aspect of a larger effort that is needed 
to improve women’s health and reduce health disparities over the life course. More 
comprehensive efforts that take into account the social context of women’s lives, 
including poverty, are needed for further reductions in PTB and disparities to be 
realized.  
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APPENDIX. PREGNANCY MEDICAL HOME RISK SCREENING FORM 
CCNC Pregnancy Home Risk Screening Form – 1st OB visit 
Practice Name: ___________________ 
First name: __________ MI___ Last name:______________  Medicaid ID#:______________   
Today’s date: __/__/____ 
EDC: __/__/____  By what criteria:  LMP         1st trimester U/S   2nd trimester U/S   
Other:_______________ 
Height: ________    Pre‐pregnancy weight: __________ Gravidity: _____  Parity: ___  ___  ___ 
Insurance type:   Medicaid     None   Other: ________________ 
OBSTETRIC HISTORY (check all that apply) 
 *Preterm birth (<37 completed weeks) 
Gestational age(s) of previous preterm birth(s): 
___________________________________ 
 Were any a result of spontaneous preterm 
labor and/or preterm rupture of the 
membranes? 
 Is this a singleton pregnancy? 
If yes to both questions, this patient is eligible for 
17P treatment. 
 *Low birth weight (<2500g) 
 *Very low birth weight (<1500g) 
 Fetal death >20 weeks 
 Neonatal death (within first 28 days of life) 
 Second trimester pregnancy loss 
 Three or more first trimester pregnancy losses 
 Cervical insufficiency 
 Gestational diabetes 
 Postpartum depression 
 Hypertensive disorders of pregnancy  
 Eclampsia 
 Preeclampsia 
 Gestational hypertension 
 HELLP syndrome 
CURRENT PREGNANCY (check all that apply) 
 *Multifetal gestation 
 *Fetal complications: 
 Fetal anomaly 
 Fetal chromosomal abnormality 
 Intrauterine growth restriction (IUGR) 
 Oligohydramnios 
 Polyhydramnios 
 Other: ____________________ 
 *Chronic condition which may complicate 
pregnancy: 
 Diabetes   
 Hypertension 
 Asthma 
 Mental illness  
 HIV 
 Seizure disorder 
 Renal disease 
 Systemic lupus erythematosus 
 Other(s): _____________________ 
 *Current use of drugs or alcohol/recent drug 
use or heavy alcohol use (month prior to 
learning of pregnancy) 
 *Late entry into prenatal care (>14 weeks) 
 Cervical insufficiency 
 Gestational diabetes 
 Vaginal bleeding in 2nd trimester 
 Hypertensive disorders of pregnancy 
(eclampsia, preeclampsia, gestational 
hypertension, HELLP syndrome) 
 Short interpregnancy interval (<12 months 
between last live birth and current pregnancy) 
 Current sexually transmitted infection 
 Recurrent urinary tract infections (>2 in past 6 
months, >5 in past 2 years) 
 Communication barriers: 
 Literacy 
 Disability  
Explain: ___________________________ 
 Non‐English speaking 
Primary language: ___________________ 
 Provider requests pregnancy care management 
assessment 
Reason(s)/Comments:_________________________ 
Items marked with a * will trigger automatic follow‐up by a 
pregnancy care manager. If you would like a care manager to 
assess this patient, and none of the * conditions are marked, 
check the box above. 
Name of person completing form: ___________________________________ 
Signature: _________________________________ 
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CCNC Pregnancy Home Risk Screening Form – 1st OB visit 
Complete this side of the form and give it to the nurse or doctor. Please answer as 
honestly as possible so we can provide the best care for you and your baby. The care 
team will keep this information private. 
 
 
 
 
 
 
 
 
 
 
1. Thinking back to just before you got pregnant, how did you feel about becoming 
pregnant? 
 I wanted to be pregnant sooner. 
 I wanted to be pregnant now. 
 I wanted to be pregnant later. 
 I did not want to be pregnant then or any time in the future. 
 I don’t know. 
2. *Within the last year, have you been hit, slapped, kicked or otherwise physically hurt 
by someone?      Yes   No 
3. *Are you in a relationship with a person who threatens or physically hurts you? 
   Yes   No 
4. *Has anyone forced you to have sexual activities that made you feel uncomfortable? 
   Yes   No 
5. In the last 12 months were you ever hungry but didn’t eat because you couldn’t 
afford enough food?    Yes   No 
6. *Do you have a safe and stable place to live?     Yes   No 
7. *Which statement best describes your smoking status? Check one answer. 
 A. I have never smoked, or have smoked less than 100 cigarettes in my lifetime. 
 B. I stopped smoking BEFORE I found out I was pregnant and am not smoking now. 
 C. I stopped smoking AFTER I found out I was pregnant and am not smoking now. 
 D. I smoke now but have cut down some since I found out I was pregnant. 
 E. I smoke about the same amount now as I did before I found out I was pregnant. 
8. Did any of your parents have a problem with alcohol or other drug use?    
 Yes   No 
9. Do any of your friends have a problem with alcohol or other drug use?      
 Yes   No 
10. Does your partner have a problem with alcohol or other drug use?   
 Yes   No 
Name: _______________________ Date of birth: __________________
Today’s date: ________________ 
Address: _____________________________________________________________________________ 
County: ____________  Home phone number: ____________  
Work/other phone number: ______________ 
Cell phone number: _____________________  Social security number: _____________________ 
Race:   American‐Indian or Alaska Native  Asian  Black/African‐American     
  Pacific Islander/Native Hawaiian White Other (specify):__________ 
Ethnicity:   Not Hispanic  Cuban Mexican American  Puerto Rican   Other Hispanic 
124 
11. In the past, have you had difficulties in your life due to alcohol or other drugs, 
including prescription medications?              
   Yes   No 
12. Before you knew you were pregnant, how often did you drink any alcohol, including 
beer or wine, or use other drugs?   Not at all  Rarely  Sometimes 
  Frequently 
13. In the past month, how often did you drink any alcohol, including beer or wine, or 
use other drugs? 
Not at all  Rarely  Sometimes    Frequently 
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